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ABSTRACT 
Temporomandibular joint (TMJ) “closed lock” (CL) is a clinical condition causing TMJ pain and limited 
mouth opening (painful locking) that is mostly attributed to disc displacement without reduction 
(DDwoR), or less commonly to anchored disc phenomenon (ADP). Both conditions are described 
clinically as CL which can be ‘acute’ or ‘chronic’ depending on the duration of locking. There is, 
however, no consensus about the duration of locking that defines the acute state and its effect on the 
success of interventions. This review paper, therefore, aims to provide: 1) a narrative review of the 
pathophysiological need for early intervention in DDwoR and the clinical implications of acute/chronic 
CL stages on the management pathway; 2) a systematic review investigating the effects of locking 
duration on the success of interventions for CL management. Electronic and manual searches until 
mid-August/2013 were conducted for English-language studies of any design investigating the effects 
of non-surgical and surgical interventions for acute or chronic CL (DDwoR or ADP). 626 records were 
identified and 113 studies were included. Data extraction and quality assessment were completed for 
all included studies. Included studies were, however, heterogeneous and mostly of poor-quality 
leading to contradictory and inconsistent evidence on the effect of the duration of locking on treatment 
outcomes. Future high-quality trials investigating the effect of CL duration on treatment outcome are 
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needed. At present, early intervention by ‘unlock’ mandibular manipulation seems to be the most 
practical and realistic approach that can be attempted first in every CL patient as an initial 
diagnostic/therapeutic approach. 
KEYWORDS: TMJ, disc displacement without reduction, jaw locking, acute closed lock, chronic 
closed lock, locking duration. 
Introduction 
Temporomandibular joint (TMJ) disc displacement without reduction (DDwoR) is a specific subgroup 
of temporomandibular disorders (TMDs) where the disc is permanently displaced, most frequently 
anteriorly or anteromedially, to the condyle resulting in a “painful locking” (1-4). This condition of TMJ 
pain and locking is known clinically as “closed lock” (CL) (5-8). The “TMJ closed lock” term does not, 
however, always exclusively, refer to TMJ DDwoR since another condition suggested in the literature 
to have the same ‘hypomobility’ symptoms (i.e., anchored disc phenomenon ‘ADP’) (9). In this review, 
the ‘closed lock’ term has only been used to describe the clinical symptoms of the ‘two’ conditions 
(DDwoR and ADP). 
Depending on duration of locking, CL can be acute or chronic (7, 10-13). The definition of acute and 
chronic CL stages in relation to locking duration and its implications on ‘early’ management is, 
however, controversial (13, 14). This controversy is related mostly to unproven effect of locking 
duration on CL treatment outcomes. This paper, therefore, aims to provide: 
1) A narrative review of: 
a. the evidence from a pathophysiological perspective of the need for early intervention 
in the DDwoR management pathway 
b. the clinical definition and implications of acute and chronic CL stages. 
2) A systematic review of the effects of locking duration on the success of therapeutic 
interventions in CL. It is explicitly restricted to examining the evidence for the effect of 
duration of symptoms on treatment outcome as the evidence for the effect of different 
treatments on DDwoR would require a systematic review of randomised clinical trials which is 
the subject of another review currently coming to completion (15).  
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Materials and Methods 
Search Methods 
A systematic search in Medline database via Ovid for English-language TMJ CL studies was 
conducted (last update was on: 15
th
 August 2013). The Medline search strategy is available in 
Appendix-1. Additional searches were also conducted using other sources including hand-searching 
the reference lists of the included studies and relevant review articles, as well as searching the 
Google Scholar using ‘disc displacement without reduction’ and ‘closed lock’ keywords. 
Criteria for Considering Studies for the Systematic Review 
Inclusion criteria:  
Studies of any design investigating the effects of any form of non-surgical and/or surgical 
interventions on patients with clinical and/or radiological diagnosis of acute or chronic DDwoR were 
considered in this review as long as the duration of symptoms were reported. Diagnostic criteria 
accepted were: American Association of Orofacial Pain (AAOP) (acute or chronic DDwoR) (16); 
research diagnostic criteria for temporomandibular disorders (RDC/TMD) (IIb or IIc) (17); Wilkes 
stages III or IV (18); or any other bespoke study criteria that were compatible with, or comparable to, 
the aforementioned criteria. Studies involving CL patients with a ‘static’ or ‘fixed’ disc (i.e. anchored 
disc phenomenon ADP) (9, 19) were also included. 
Studies that involved other heterogeneous groups of TMD patients (e.g. osteoarthritis, myofacial pain, 
DDwR) in addition to patients with DDwoR were considered only if: separate data (e.g., success rate 
and/or locking duration) were provided in the study for DDwoR patients, or if the sample consisted of 
≥ 80% DDwoR patients. Studies involving patients with a confirmed diagnosis of DDwoR disorder with 
comorbid disorders were also included. 
Exclusion criteria:  
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Studies were excluded if they did not report the duration of symptoms of their sample or if they 
addressed diagnoses other than ‘closed lock’ (DDwoR or ADP). Studies were also excluded if they 
addressed subject matter other than CL treatment.  
Data Collection and Extraction 
Selection of Studies  
The first reviewer (MA) selected eligible studies based on the inclusion/exclusion criteria with those 
identified as clearly irrelevant from their title/abstract being excluded. The full-texts of all potentially 
eligible studies were retrieved and examined. Throughout the selection process, any doubt about a 
study’s inclusion meant it was examined by the second reviewer (JD) and the decision to include or 
exclude the study was made by discussion with the first reviewer to reach a consensus. 
Data Extraction and Management  
A standardised table was used for data extraction. The data from eligible studies were extracted and 
recorded by the first reviewer (MA). The second reviewer (JD) crosschecked the extracted data’s 
validity. The data on duration of symptoms and follow-up period were standardised in months and the 
data for visual analogue scale (VAS) pain successful outcome were standardised, when possible, to 
(0-100) scale. If not provided, the mean patient age and locking duration was calculated from the raw 
data using SPSS (IBM SPSS statistical package v.19). 
Quality Assessment 
Two independent reviewers (MA & JD) assessed the quality of study design in the included studies 
using the National Health and Medical Research Council (NHMRC) level of evidence guidelines for 
intervention trials (20) with slight modification (Appendix-2). The level of evidence in each study was 
judged by its design as: (I) highest, (II-1), (II-2), (III-1), (III-2), (III-3), or (IV) lowest. Any disagreements 
concerning the assessment were resolved by discussion to reach a consensus. 
RESULTS 
Search results  
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The search strategy identified a total of 626 records from electronic and manual searches (426 from 
MEDLINE and 200 from other sources). Of these, the full-texts of 395 potentially eligible papers were 
retrieved and examined. Eventually, 113 studies (of 122 reports) were found eligible and included in 
the systematic review. The study flow diagram is available in Appendix-3. 
Narrative review of DDwoR pathophysiology, and the clinical definition and implications of 
acute and chronic CL stages  
Pathophysiology and progression of DDwoR 
Patients with DDwoR are often characterised by distinct combinations of signs and symptoms: history 
of clicking followed by sudden onset of pain and limited mouth opening (locking without clicking) and 
impaired contralateral movement (2, 5, 7, 17, 21, 22). These characteristic symptoms are usually 
present in ‘acute’ DDwoR [CL] (painful limited opening) as opposed to ‘chronic’ DDwoR (decreased 
pain-improved opening), which makes the clinical diagnosis of the former more readily achievable. 
The latter may be difficult to diagnose clinically without magnetic resonance imaging (MRI) (11, 23). 
The incidence of DDwoR amongst TMDs is not fully determined but is estimated to occur in about 2-
8% (24-27). DDwoR is, however, also diagnosed by MRI in people without any clinical signs or 
symptoms with a reported prevalence of 3% amongst the asymptomatic general population (23, 28-
30). 
The two predominant biomedical complaints in DDwoR are TMJ pain and limitation of jaw 
movements. The exact cause of pain associated with DDwoR is still not fully understood (31). The 
displaced disc is thought to play an important role in the pain process (32-34), but it is unlikely to be 
the only source of pain as disc displacement alone is not always associated with pain (29, 35-40). In 
addition to alteration in disc position, other factors have been suggested in the development of pain: 
joint effusion and inflammatory reactions (e.g. synovitis, capsulitis, or retrodiscitis), and capsule 
impingement and/or retrodiscal tissue compression (31, 41-50). 
The other predominant biomedical complaint in DDwoR is the abrupt restriction in jaw movements. 
This is usually attributed to mechanical obstruction by the displaced disc to the translating condylar 
movement (1, 2, 5, 21, 51). This condition is often, almost colloquially, termed as “closed lock” (CL) 
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(5-8). The “closed lock” term, however, describes a clinical symptom and not an anatomic diagnosis 
and the condition of CL is not always exclusively attributed to DDwoR. Anchored disc phenomenon 
(ADP) has also been suggested as potentially responsible for some of the cases of CL (9, 52). The 
putative pathogenic processes underpinning ADP are: direct mechanical injury from joint overloading, 
hypoxia-reperfusion injury, release of free radicals into the synovial fluid, causing degradation of 
hyaluronic acid, and eventually a vacuum effect (suction cup effect). The end result of these proposed 
pathological processes leads to disc adherence to the roof of the glenoid fossa. The adhered or 
‘stuck’ disc then totally prevents the condylar sliding movement producing a more pronounced lock 
but that responds better to arthrocentesis than DDwoR (9, 52-55). Whether ADP is a distinct entity 
from DDwoR, or a differing stage of the same clinical entity, is still debatable (56) due to the degree of 
similarity between the signs and symptoms of the two conditions. This similarity makes the 
differentiation of the two conditions based on clinical diagnosis alone virtually impossible and 
differentiation on the basis of MRI (19) is doubtful as all bar one ADP study (57), involve patients with 
displaced discs as well as normally positioned discs (55, 58, 59). Further studies with MRI evidence of 
a normally positioned disc in CL patients are required to gain a better understanding of ADP and 
whether it is a separate entity within the “closed lock” category (57, 60). 
The course of DDwoR disorder has been shown to be ‘favourable’ (14, 61-66). Studies on the natural 
course of ‘chronic’ DDwoR have shown that in about two thirds of patients, the clinical signs and 
symptoms tend to resolve or improve over a period of (6-30 months) while the other one third did not 
improve or became worse during the observation period (14, 61, 63, 67). A recent study on the short-
term natural course of ‘acute’ DDwoR demonstrated that signs and symptoms resolved in 95% of 
patients over 3 months of observation (68).  
The improvement over the time in some patients with DDwoR may be attributed to stretching and 
remodelling of the retrodiscal tissues and “pseudo” disc adaptation (44, 69-74). Despite the increased 
range of jaw motion and decreased pain, several studies have demonstrated that the displacement of 
the disc and the deformation of the disc-condyle complex increases (14, 61, 63, 65, 75-81). There are 
also some indications that the permanently displaced disc may be correlated with alterations in 
maxillofacial skeletal morphology in the long-term (82-88).  
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The TMJ is a load-bearing joint and its articular tissues have a remarkable adaptive capacity to 
mechanical loading (89-91), but this capacity is not infinite. Sustained overloading may increase the 
susceptibility to degenerative joint disease (31, 71, 92-94) and other risk factors may adversely 
influence the adaptive capacity of the articular tissues including: age, systemic illness, hormonal, 
nutritional, traumatic, mechanical, and genetic factors (91, 92, 95-99). A degenerative state can, 
therefore, ensue if functional demands surpass the adaptive capacity or if the affected individual is 
susceptible to maladaptive responses (92). In general, the molecular events that underlie TMJ 
remodelling and adaptation are still not fully understood (92) and the molecular and cellular basis of 
DDwoR pathophysiology is still unclear but there is some biochemical evidence of increasing 
susceptibility to osteoarthritic degeneration in ‘chronic’ CL patients (100-107). 
Three models have been proposed that may be involved in the pathogenesis of degenerative TMJ 
diseases: the direct mechanical trauma model, the hypoxia reperfusion model, and the neurogenic 
inflammation model (108). The molecular events and cascades in response to mechanical stress in 
these models may ultimately lead to an imbalance between catabolic and anabolic events leading to 
catabolism (degeneration) of the articular tissues in the affected joints (91, 92). The risk of 
degenerative changes in joints with DDwoR was shown to be four times greater than in joints with 
normal disc position (109) and suggestions were made that the propensity for degenerative disease 
was mediated by an imbalance in the patient’s adaptive capacity and functional loading of the TMJ. 
The study concluded that a careful, individualised, assessment of each DDwoR patient was required 
in order to evaluate the various factors that might contribute towards the progression to degenerative 
disease (109). 
At present, the line separating normal adaptive responses from responses that result in 
(degenerative) disease is ill-defined. It may, therefore, be difficult to predict the DDwoR prognosis in 
an individual patient (71). In fact, TMJ DDwoR is a disorder with two possible scenarios. On one 
hand, it is a benign self-limiting disorder in which most of patients’ symptoms improve with the 
passage of the time and do not necessarily progress to degenerative joint disease (69, 77, 110, 111). 
On the other hand, DDwoR can be also a debilitating disorder causing significant pain and 
dysfunction that disturbs the patient’s quality of life with the potential for persistence of symptoms and 
degenerative progression in susceptible patients in the longer term (71, 109, 112-115). Both 
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scenarios are possible in DDwoR patients and it is still not clear which patients have, or which 
biomechanical and biochemical factors predict, the greatest risk for progressing to the more advanced 
stages (116). This means that it is important to treat all patients early in the time course of DDwoR in 
order to prevent disease progress in susceptible patients (117-119). This ‘early’ management will also 
prevent progression from an acute to a chronic condition thereby avoiding the possibility of developing 
chronic pain and its psychosocial consequences in symptomatic DDwoR patients (120-122). Any 
initial active intervention, however, should be simpler and less invasive than waiting for possible 
symptomatic resolution during the ‘favourable’ natural course of the DDwoR disorder (68). 
Clinical definition and implications of acute versus chronic CL stages 
The term “acute” is usually related to a temporary state or condition which may or may not be severe, 
whilst the term “chronic” is related to a state or condition that is persistent or long lasting and again 
does not imply anything about severity (123, 124). Both medical terms are often used as measures of 
the time scale of a disease rather than its severity. In pain conditions, “acute pain” usually refers to 
pain of recent onset with a duration ≤ 1 month (≤ 30 days), whilst “chronic pain” usually refers to a 
persistent pain with a longer duration (≥ 3 months or ≥ 90 days) (125, 126). In a CL condition, the 
terms “acute closed lock” (ACL) and “chronic closed lock” (CCL) are widely used in the CL literature 
usually describing the chronicity of DDwoR. The most reliable diagnostic criteria for TMDs (17, 22, 
127-129) depend, however, primarily on the patients’ signs and symptoms rather than the duration of 
symptoms in order to classify acute versus chronic DDwoR (Appendix-4). In clinical trials involving 
patients with DDwoR, however, most authors usually define their samples based on the duration of 
symptoms (i.e. locking duration or time since DDwoR onset) although there is considerable variation 
in the threshold that defines acute and chronic stages ranging from 1 to 6 months (Appendix-5). In the 
authors’ opinion, a more appropriate clinical classification of acute and chronic CL could be based on 
the time-scale for the possibility of recapturing the displaced disc to return the DDwoR to its previous 
condition (i.e. disc displacement with reduction ‘DDwR’) with a non-invasive intervention.  
In DDwoR (CL), both patient and management factors have been suggested to predict the outcomes. 
The predictors suggested include: age, gender, level of pain, range of mandibular motion, duration of 
locking, joint inflammation, disc mobility, severity of disc displacement, stage and degree of 
morphological and pathological changes in disc-condyle complex, and type, frequency, and duration 
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of therapy (114, 130-144). The role of these factors in predicting CL treatment outcome is, however, 
still debatable. In fact, these ‘prognostic’ factors may interrelate or interact with each other to a greater 
or lesser degree and there are still not significant data on the role psychosocial factors may have in 
predicting outcome in CL. To give an example: the severity of intra-articular pathological changes and 
the stage of internal derangement may increase with the age of the patient and/or duration of locking. 
Some of the aforementioned predictive factors are, however, easily accessible through standard 
history and examination whereas others require either more advanced imaging (e.g., MRI) or 
investigations (e.g., arthroscopy). Duration of locking is very simply estimated by self-report, although 
the accuracy of report may be influenced by several factors including recall bias. 
The possible mechanism for jaw locking and DDwoR progression from ‘acute’ to ‘chronic’ has been 
proposed to begin as a displaced disc obstructing the forward condylar translation resulting in 
restricted mouth opening (acute stage); the repeated attempts to increase mouth opening then 
displace the disc gradually farther forward to an anterior position, so the condyle can slide forward, 
and the mouth opening range increases with the ‘time’ (chronic stage) (2, 116, 145). From a clinical 
perspective, the progression from an acute to a chronic DDwoR over the time can affect treatment 
outcome as patients may respond differently to a similar therapeutic intervention dependent on 
locking duration (114, 146). This coupled with the fact that the two most frequently measured 
outcomes to assess treatment effectiveness tend to improve over time (increased opening and 
decreased pain) (131), may be one of the reasons for confusing outcomes reported in the literature 
around the management of DDwoR: the effectiveness of treatments and authors’ findings in their 
studies may vary because of varying levels of chronicity in their sample. A systematic review of CL 
studies was, therefore, conducted to investigate the effects of locking duration on the success of 
therapeutic interventions. 
Systematic review of effects of interventions in relation to CL duration  
Multiple different non-surgical and surgical treatment modalities have been used for CL management. 
The interventions identified from the studies included in this review were defined according to their 
main treatment components: mandibular manipulation (MM); self-management (SM); physiotherapy 
(PT); splint therapy; combination therapy of splint + PT ± SM; arthrocentesis (AC); arthroscopy (AS); 
open surgery (OS). A detailed description of each treatment strategy is available in Appendix-6. 
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To investigate the effects of interventions in relation to locking duration, the characteristics and quality 
of the included studies were tabulated and summarised in Tables 1-6. The interventions’ success 
rates provided in the tables are based on the success criteria used by each included study. The 
definition of success was, therefore, highly variable involving both objective and subjective factors 
with the most frequent measures being mouth opening and pain levels (Tables 1-6). 
Summary of intervention effects in relation to locking duration  
Mandibular manipulation (MM): Nineteen included studies used different unlock manipulation (UM) 
techniques on DDwoR patients with a mean locking duration of 9 months (range: 0.03-180 months). 
The most commonly used UM technique is Farrar’s technique (2) (described in Appendix-7 ‘figure’) 
and the most commonly used splint after recapturing the displaced disc is the anterior repositioning 
splint (ARS). The UM success rate was variable ranging from 9% to 100% (mean: 68%). Pumping 
manipulation (PM) was used in 6 studies on DDwoR patients with a mean locking duration of 8 
months (range: 0.07-120 months) and had comparable success rate to UM. Among all the included 
studies on MM, 9 studies used post-operative imaging to assess disc recapturing with a mean 
success rate of 44% (range: 4%-100%) (Table-1). 
Self-management (SM) and physiotherapeutic (PT) interventions: Self-management involving self-
exercises with medication and self-care instructions and education was used on DDwoR patients in 7 
studies with a mean success rate of 66%. Only 2 studies evaluated the jaw stretching exercises by 
physiotherapists as the sole treatment on patients with DDwoR having locking duration ranging from 
several weeks to several years with high success rate (Table-2). 
Splint therapy: Occlusal splints were either used as a main treatment strategy or as an adjunct 
treatment to other interventions in the management of DDwoR. In 12 studies, different types of splints 
were used independently as the sole treatment for DDwoR patients with a mean locking duration of 
16 months (range: 0.25-192) with a variable success rate ranging from 13% to 100% (mean: 60%). 
The adjunctive use of splints with other conservative interventions was employed by 10 studies with 
DDwoR patients how had a mean locking duration of 10 months resulting in a mean success rate of 
84% (range: 71%-100%) (Table-3).  
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Arthrocentesis (AC): Arthrocentesis was used in 32 studies on patients with a mean CL duration of 10 
months (range: 0.03-109 months) with a success rate ranging from 22% to 100% (mean: 73%). The 
AC success rate was, however, higher in ADP (91%) than DDwoR (65%) studies (Table-4).  
Arthroscopy (AS): Thirty-two included studies used arthroscopy on patients with a mean CL duration 
of 19 months (range: 0.25-163 months) with a success rate ranging from 50% to 100% (mean: 79%)  
(Table-5).  
Open surgery (OS): Open joint surgery was used in 8 studies on CL patients with a mean locking 
duration of 22 months (range: 0.5-150 months) with a success rate ranging from 70% to 100% (mean: 
86%) (Table-6). 
Quality of included studies  
Most of the included studies were of poor-quality and had various methodological weaknesses in their 
design. Specifically, most were either uncontrolled studies or had incompletely defined or controlled 
for other prognostic factors that may influence treatment outcome. The level of evidence was, 
therefore, generally of a low grade (III-IV). 
Discussion  
There was considerable heterogeneity among the studies included in the systematic review of locking 
duration. Although the studies were grouped based on their treatment modality, there were 
considerable variations in: study design, diagnostic and inclusion criteria, intervention delivery, 
techniques and combinations, outcome measures, success criteria, and follow-up periods. These 
findings were, however, expected before undertaking this review as one of the aims of this paper was 
to investigate if there is any relationship between treatment outcome and CL duration rather than to 
identify the scientific evidence for clinical effectiveness of interventions used in managing DDwoR. 
The latter is best accomplished through a systematic review of randomised clinical trials in DDwoR 
management which is nearing completion (15). 
To the best of the authors’ knowledge, this is the first comprehensive and systematic review that 
examines the effect of duration of locking on treatment outcome. There were, however, some 
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limitations in the review process. A systematic search was performed in only one database for 
English-language publications. Searching multiple databases without language restrictions may have 
yielded more results. Furthermore, there were large number of CL studies that did not report the 
duration of symptoms in their study sample and so we had to exclude them. This was also true for 
many surgical trials including CL patients’ not-responding to non-surgical interventions for more than 
3 or 6 months (CCL). Nevertheless, the large number of studies included in this review represented all 
of the various treatment modalities used for acute and chronic CL management.   
The quality assessment of the included studies was based solely on study design. This is a 
convenient way to summarise the studies according to their designs (20), but does not completely 
illustrate the strength of the evidence, as study design is only one of several components contributing 
to this. 
The studies included were mostly uncontrolled and did not examine the placebo effect or the possible 
symptomatic resolution over time (68, 245) and only a few attempted, with adequate statistical power, 
to analyse the treatment effects by duration of symptoms on a large sample size. This is most likely 
due to difficulty in recruiting patients with a DDwoR ‘acute/chronic’ diagnosis which may take several 
years (168, 211). Given the low incidence of DDwoR amongst TMDs, a multi-centre RCT may be the 
most appropriate manner by which to examine the effect of CL duration on the outcome of initial non-
invasive simple treatments in DDwoR. To organise such a trial, consensus would need to be reached 
both on the definition of acute and chronic DDwoR in order to allow stratification of treatment groups, 
and on the standardised multidimensional outcome measures that are of importance in DDwoR. In the 
studies included, the most widely used outcomes to assess DDwoR improvement were pain intensity 
and mouth opening. In addition to these, the authors would suggest to include functional limitation, 
multi-dimensional pain assessment and some form of quality of life assessment (246-251). 
Standardised, but ‘pragmatic’, success criteria are also needed to yield more rigorous research (169). 
Given the clinical and/or statistical heterogeneity of studies included, the main study findings of 
treatment effect in relation to CL duration were summarised by each individual study in the tables 1-6. 
Overall, the evidence for the effect of locking duration on treatment outcome is contradictory and 
inconsistent. It may seem that the degree of intra-articular pathological changes is more important 
than the locking duration but this could not be established.  
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In general, there were a limited number of studies using clear and robust diagnostic criteria, which 
attempted to examine treatment effects by duration of symptoms. What we are left with is 
comparisons between interventions targeting many different assumed causative factors of which 
locking duration forms only a small part. It is doubtful that a single prognostic factor determines 
successful outcome in CL management and it has to be acknowledged that it is likely that several, as 
yet undefined, factors influence the outcome of CL management including not only the biomedical 
factors but also the patients’ psychosocial phenotype (252-257). It does, however, seem entirely 
reasonable, within the ethos of modern medicine, and consistent with recent guidance on the 
management of TMDs (258) that until we have a better understanding of these factors, we should 
avoid invasive interventions in the initial phases of CL management. Following on from this it makes 
intuitive sense, therefore, to consider a stepped ‘timely-management’ approach to treat patients with 
symptomatic CL (169), starting with the simplest, least invasive intervention (e.g., self-management 
with ‘early’ manipulation) and escalating the treatment only if needed (e.g., rehabilitation by splint 
and/or physiotherapy) and to defer surgery (e.g., first-line arthrocentesis then arthroscopy) for 6 
months or more. Differences in DDwoR patients’ complaints such as the presence/absence of pain or 
mouth opening limitation may affect the necessity for a specific treatment but this stepped approach 
is, in general, the most realistic.  
The simplest, least costly, quickest, and non-invasive approach that can be easily employed (by 
general practitioners) with symptomatic DDwoR patients at the first point of contact is the ‘unlock’ 
mandibular manipulation which has some initial evidence to support its efficacy in ‘early’ intervention 
in DDwoR. Much about this intervention, however, still remains unanswered as there was no 
consensus on: technique of manual manipulation applied, who delivers the intervention (patient or 
clinician), and what, if any, post-treatment splint type is further needed to ensure the long-term 
successful 'stable' results. Further research is, therefore, required in this group of interventions and 
should also include pre- and post-operative MRI in order to assess the UM effect on disc position 
(156). In this review, the time after which the UM should not be attempted could not be determined 
(i.e. time-frame for ‘disc recapturing’ possibility). Nevertheless, this treatment modality can aid both 
diagnosis and treatment and unlikely to have adverse effects. There are, therefore, few significant 
contraindications to justify postponement of attempting to treat DDwoR through this simple approach. 
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Conclusion  
In DDwoR management, several factors can predict the treatment outcomes, one of which is the 
duration of locking. The effect of locking duration on treatment outcome, however, remains a matter of 
controversy in the literature. Despite that, clinical staging of DDwoR based on locking duration is one 
of the few factors that can be easily addressed from patient’s history especially in acute closed lock 
as the patients can usually remember the sudden onset of locking of short duration. Future diagnostic 
classifications for DDwoR should seek to address and define the acute versus the chronic period in 
relation to locking duration (i.e. time since DDwoR onset). This classification may then advance 
understanding and help target the available therapies more effectively. Until we have a better 
understanding, a stepped approach to CL management is indicated, starting with the simplest, 
cheapest, quickest, and most practical first diagnostic and treatment approach for this condition at the 
first given opportunity in the patient’s healthcare journey. This intervention based on current evidence 
would seem to be an ‘unlock’ mandibular manipulation. 
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Tables: 
Table 1: Characteristics of included mandibular manipulation (unlock manipulation UM or pumping manipulation PM) studies. 
Study
 
(Year) 
Study 
design 
Participants’ characteristics 
Main Intervention 
assessed  
Longest 
follow-up 
duration 
(months) 
Success criteria 
Study findings in relation 
to CL duration 
Overall 
success 
rate % 
(ITT use) 
Study 
design 
quality 
Sample 
size 
(drop/exc) 
Study 
diagnosi
s 
Gender 
Age  
(years) 
Locking duration 
(months) 
M F Range Mean Range Mean ± SD 
Chiba and 
Echigo (2005) 
(117) 
CR 1 
DDwoR 
(ACL) 
- 1 21 - 0.33 - 
Farrar’s UM
 a
 under 
LA + ARS 
137 
Decreased pain, 
cMMO≥40mm, & 
DR on MRI 
- - IV 
Correa et al. 
(2009) (147) 
CR 1 DDwoR - 1 18 - 36 - 
UM under LA 
+ ARS, NSAIDs, 
cryotherapy 
24 cMMO>40mm - - IV 
Foster et al. 
(2000) (148) 
PNCoSt 
55 
(19) 
22 CL 
(DDwoR)  
& 14 IL 
7 48  15-52 24 3-48 13 
Forced UM under GA  
+ Self-care ± Splint 
3 
MMO≥35mm & 
subjective 
improvement 
The range of locking 
duration (6-48) was similar 
in SG & UG. 
CL: 40.9% 
(no ITT) 
III-3 
Helkimo and 
Hugoson 
(1988) (149) 
PCS 10 DDwoR 3 7 17-63 29.4 1-36 12.2 
Farrar’s UM under 
N2O/O2 sedation + 
SS 
6 
Improvement in: 
pain,  jaw 
dysfunction (Di: I-
II), LM, & 
MMO≥40mm 
Longer locking duration in 
UG 20 (12-36) than in SG 
10.8 (1-30). 
60% IV 
Hernandez 
and Karibe 
(2004) (150) 
CR 1 DDwoR - 1 - 28 0.25 - 
UM under LA 
+ Med, PT (US), SS, 
Self-exercises 
1 MMO≥40mm - - IV 
Jagger (1991) 
(151) 
PCS 12 DDwoR 4 8 15-43 21.8 1-9 3 UM (own technique) - MMO≥35mm 
Locking Duration is not an 
important factor for UM 
success 
66.7% IV 
Kai et al. 
(1993) (152) 
PCS 12
 b
 DDwoR 1 11 11-61 30.33 0.1-2 0.5±0.53 UM or PM + ARS 1 
Improvement in 
clinical symptoms 
& MMO≥40mm 
58.3% DR on arthrography 66.7% IV 
Kurita et al. 
(1999) (132) 
PNCoSt 
74/215 
assessed 
by MRI 
DDwoR 7 67 - 32.5 - 11.4 
Farrar’s UM 
+ ARS or NSAID or 
SS 
Few wks DR on MRI 
No significant difference in 
locking duration between 
successful DR (10±19.1) 
and no DR (12.8±24.6). 
18% 
(no ITT) 
9% 
(ITT) 
III-3 
Liu et al. 
(2012) (153) 
RNCoSt 36 
23 CL 
(DDwoR) 
& 13 IL 
6 30 13-31 19.8 < 3 - 
UM under LA  
+ ARS 
6 
Improvement in: 
pain, MMO, & jaw 
dysfunction.  
- 
DDwoR: 
69.6% 
IV 
Martini et al. 
(1996) (154) 
PCS 
13/1500 
reported 
DDwoR - - 19-56 31.4 0.23-180 
36.02±53.4
7 
UM (own technique) 
+ ARS, PT 
2-24 
Absence of pain, 
MMO≥35mm, & 
DR on MRI 
Locking duration is not 
related to UM success. 
99.7% IV 
Minagi et al. 
(1991) (135) 
PCS 35 DDwoR 2 33 12-68 35.94 0.25-18 3.26±4.09 UM (own technique) - MMO≥40mm 
No difference in success 
rate between <1mo (50%) & 
>1mo (53%) duration. 
51.4% IV 
Mongini et al. 
(1995; 1996) 
(113, 155) 
PCT 
 
75 
(7) 
 
DDwoR 7 68 13-43 27.8 0.25-120 13.3±21.84 
Extra-oral UM  
under LA 
+ ARS, SS, Med, PT 
18-147 
No pain or pain 
present only on 
jaw movement & 
MMO≥35mm  
No difference in locking 
duration between SG & UG. 
4.4% DR on MRI. 
86.8% 
(no ITT) 
IV 
Muhtarogullar
i et al. (2013) 
(156) 
PNCoSt 22 DDwoR 3 19 14-48 27.1 - 3.25 
UM + ARS  
if unsuccessful DR: 
SS+ Self-exercises 
6 
No pain on 
palpation, 
MMO≥40mm, 
normal LM & PM 
15.9% DR on MRI 100% III-3 
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Table 1 (Continued): 
Study
 
(Year) 
Study 
design 
Participants’ characteristics 
Main Intervention 
assessed  
Longest 
follow-up 
duration 
(months) 
Success criteria 
Study findings in relation 
to CL duration 
Overall 
success 
rate % 
(ITT use) 
Study 
design 
quality 
Sample 
size 
(drop/exc) 
Study 
diagnosi
s 
Gender 
Age  
(years) 
Locking duration 
(months) 
M F Range Mean Range Mean ± SD 
Murakami et 
al. (1987) 
(157) 
PCS 10 DDwoR 1 9 14-46 28.9 1-9 4.7 PM + CS + ARS 6 
AAOMS criteria: 
increase in cMMO 
No difference in locking 
duration between SG & UG. 
PM helps to unlock the CL 
up to about 6mo. 
70% IV 
Murakami et 
al. (1995)  
(12)
 c
 
PCoSt 108 
W: III 
(CL) 
20 88 - 31.43 - 
5.0±8.8 
NS: Med/UM/PS, 
N=63  
6 
VAS pain<20, 
MMO>38 mm, LM 
& PM> 6mm, & 
improved DAL 
Patients with >7m locking 
duration did not respond to 
arthrocentesis 
NS: 55.6% 
(Md:15.9% 
UM:18.9% 
PS: 33.3%) 
AC: 70% 
AS: 91% 
III-2 5.6±6.9 AC, N=20 
6.8±10.2 AS, N= 25 
Ohnuki et al. 
(2006) (137)
 c
 
RCoSt 85 DDwoR 9 76 13-73 41.8 - 
5.1±6.8 SS, N=11 
12 
VAS pain<20 & 
MMO>38mm 
No significant difference 
between SG regarding 
locking duration. 10% DR 
on MRI among all groups 
with no difference between 
groups. 
Med: 0% 
SS: 12.9% 
PM: 44.6% 
AC: 22% 
AS:100% 
III-3 
10.4±13.1 PM, N=33 
6.6±8 AC, N=9 
14.2±22.2 AS, N=32 
Ozawa et al. 
(1996) (158) 
RCS 40 DDwoR 4 36 16- 68 38.15 
 
0.1-120 
 
19.58±33.9
98 
PM  
ACL (0.1-0.27),N=5 
CCL (2-120),N=35 
0.07-3 
(ACL:2-3dy 
CCL:2-3mo) 
Improvement in 
pain & 
MMO≥35mm 
Higher success rate in ACL 
(100%) than in CCL 
(37.1%). PM able to release 
acute locking only. 
68.6% IV 
Segami et al. 
(1990) (139) 
PCS 28 DDwoR 3 25 14-57 25.4 0.07-24 4.7 
Farrar’s UM or PM  
+ ARS & NSAIDs 
2 
No or slight pain & 
MMO≥40mm 
No relation between MM 
technique (UM or PM) & 
locking duration. 36.7% DR 
on arthrography.  
100% IV 
Simmons 
(2002) (159) 
CR 1 DDwoR - 1 - 14 0.5 - 
PM under IV-
sedation + ARS 
24 
Improvement in:  
cMMO, LM, PM, 
subjective 
improvement, & 
DR on MRI 
- - IV 
Singh (2010) 
(160) 
CR 1 
DDwoR 
(Chronic) 
- 1 - 32 24 - 
UM under LA with 
CS +  IMF screws & 
elastics + ARS 
0.25 
Improvement in:  
VAS pain, cMMO 
- - IV 
Van Dyke and 
Goldman 
(1990) (161) 
PCS 41 
DDwoR 
(Acute) 
- - - - ≤1.5-2 - 
UM under IM-LA 
(own tech) + ARS 
- MMO≥40mm - 92.7% IV 
Yoshida et al. 
(2005) (141) 
RCT 305 DDwoR 76 229 18-74 - 
0.033-
<12 
- 
UM (own technique)  
+ NSAID, N=204 
NSAID only, N=101 
0.25 
VAS pain<20, 
MMO≥36mm, 
LM≥6mm, & DR on 
MRI 
UM success rate drops 
significantly with the 
increase in locking duration: 
1-2dy (100%), <1wk 
(98.3%), <2wk (94.6%), 
<3wk (90%), <1m (57.1%), 
<2mo (16.7%), <6mo (0%). 
UM: 84.3% 
NSAID:0% 
II-2 
Yoshida et al. 
(2011; 2013) 
(114, 162) 
RCT 148 DDwoR - 148 19-75 40 
0.033-9 1.57 Self-UM, N=74 
10 minutes 
Absence of pain & 
MMO>38mm  
Locking duration was 
shorter in SG (1.18) than in 
UG (2.92).  
S-UM:68% 
Ctrl:4% 
II-2 
0.067–11 1.73 No treatment, N=74 
TOTAL 
19studies - DDwoR - - - - 0.03-180 8.93 UM - - DR average success rate: 
44% (range: 4.4%-99.7%) 
67.6% - 
6studies - DDwoR - - - - 0.07-120 7.98 PM - - 69.9% - 
29 
 
Study Design abbreviations: RCT: randomised controlled trial, Q-RCT: quasi-randomised controlled trial, PCoSt: prospective comparative study, RCoSt: retrospective comparative study, PCCSt: prospective case-control study, PNCoSt: 
prospective non-comparative study, RNCoSt: retrospective non-comparative study, FSt: follow-up study, PCS: prospective case series, RCS: retrospective case series, BACS: before-after case series, BACR: before-after case report, CR: 
case report. 
Abbreviations: AAOMS: American association of oral and maxillofacial surgery, ACL: acute closed lock, ARS: anterior repositioning splint, CCL: chronic closed lock, Ch: chronic, CMI: craniomandibular index, cMMO: comfortable ‘painless’ 
maximum mouth opening, CS: corticosteroids, Ctrl: control, DAL: daily activity limitation, DDwoR: disc displacement without reduction, DR: disc recapturing, drop: drop-outs, dy: day, exc: excluded, Exr: exercises, F: female, GA: general 
anaesthesia, IL: intermittent locking, IM: intra-muscular, IMF: inter-maxillary fixation, ITT: intention-to-treat analysis, IV: intra-venous, j: joint, LA: local anaesthesia, LDF: limitation in daily function, LM: lateral movement, M: male, Med: 
medication, MFIQ: mandibular function impairment questionnaire, mm: millimetres, MMO: maximum mouth opening, mo: month, MR: muscle relaxant, MRI: magnetic resonance imaging, N: number of patients, NR: not reported, NS: non-
surgical, NSAIDs: non-steroidal anti-inflammatory drugs, OA: occlusal adjustment, PM: protrusive movement, PM: pumping manipulation, PS: pivot splint, PT: physiotherapy, S&S: signs and symptoms, SD: standard deviation, SG: 
successful group, SS: stabilization splint, Sub-ac: sub-acute, UG: unsuccessful group, UM: unlock manipulation, US: ultrasound, VAS: visual analogue scale, W: Wilkes staging of internal derangement, wk: week, yr: year. 
a
 Description of Farrar’s UM technique (2) is available in Appendix-7 (figure). 
b 
Separate data provided are for DDwoR patients only. 
c
 Study data are also provided in other tables according to main treatment modality assessed. 
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Table 2: Characteristics of included self-management (SM) and physiotherapy (PT) studies. 
Study
 
(Year) 
Study 
design 
Participants’ characteristics 
Main interventions 
assessed 
Longest 
follow-up 
duration 
(months) 
Success criteria 
Study findings 
in relation to 
CL duration 
Overall 
success 
rate % 
(ITT use) 
Study 
design 
quality 
Sample 
size 
(drop/exc) 
Study 
diagnosis 
Gender 
Age  
(years) 
Locking duration 
(months) 
M F Range Mean Range Mean ± SD 
 
Braun (1987) 
(163) 
 
CR 1 DDwoR - 1 - 71 0.75 - 
Self-exercises + 
Iontophoresis 
1.5 
Absence of pain, 
MMO>40mm, 
LM>7mm, improved 
jaw function, & eating 
normal diet 
- - IV 
Cleland and 
Palmer (2004) 
(164) 
BACR 1 DDwoR - 1 - 24 19 - SM + PT 3 
VAS pain<20, 
MMO≥40mm, & 
improved jaw function 
- - IV 
Craane et al. 
(2012) (165) 
RCT 
49 
(7) 
DDwoR 2 47 - 36.6 wks-yrs - 
Exercises, N= 23 
Education only, N= 26 
13 
Improvement in: VAS 
pain, MMO, & MFIQ 
- 
- 
(ITT) 
II-1 
Haketa et al. 
(2010) (145)
 a
 
RCT 
52 
(14) 
DDwoR 6 46 - 37.6 Over 0.5 - 
Self-care+ SS, N=25 
Self-care+ Self-exercise, 
N=19 
2 
Improvement in: VAS 
pain, MMO, & LDF 
- 
- 
(ITT) 
II-1 
Minakuchi et 
al. (2001; 
2004) (166, 
167)
 a
 
RCT 
69 
(8) 
DDwoR 7 62 - 34 - 
3.89±5.56 Education only, N=21 
2 
Improvement in: VAS 
pain, MMO, & DAL 
- 
- 
(ITT) 
II-1 2.81±5.09 Self-care/NSAIDs, N=23 
3.12±5.03 
SS+ Exercises + Self-
care/NSAIDs, N=25 
Nicolakis et 
al. (2001) 
(136) 
BACS 
20  
(2) 
 5 15 - 37.3 1.2-60 15.6 
Active & passive jaw 
exercises 
6 
Improvement in: VAS 
pain, MMO, & DLA 
- 
85% 
(ITT) 
III-3 
Schiffman et 
al. (2007; 
2013) (168, 
169) 
a
 
RCT 
108 
(12) 
W: III-IV 
(DDwoR) 
8 98 - 31.72 
Non-ch 
<6 - ch≥6 
- 
SM + Med, N=29 
SS + PT + CBT, N=25 
AS + CS, N=26 
OS, N=26 
60 
Self-reported success  
(Patient satisfaction) 
- 
SM: 72% 
Reh: 81% 
AS: 76.2% 
OS: 83.3% 
(ITT) 
II-1 
Srisintorn 
(1992) (170) 
CR 1 DDwoR - 1 - 29 2 - 
Self-care/NSAID + Self-
exercises 
12 cMMO≥40mm - - IV 
Yuasa and 
Kurita (2001) 
(142) 
RCT 
60 
(NR) 
DDwoR  
(15ACL, 
45CCL) 
12 48 16-69 
Median
28 
0.53-
25.07 
Median 
2.33 
NSAIDs + self-exercise, 
N=30 
1 
AAOMS & IAOMS 
modified criteria:  
VAS pain≤33 & 
MMO≥35mm 
CCL (>1 mo) 
responded better 
to treatment than 
non-treatment in 
comparison with 
ACL (≤1 mo) 
SM: 60% 
Ctrl: 33% 
(ITT) 
II-1 
0.63-41.8 3.27 No treatment, N=30 
Total  
2studies - DDwoR - - - - - - PT (Stretching exr.)  - - - - - 
7studies - DDwoR - - - - - - SM (self-care/Med/Exr) - - - 66% - 
Study Design abbreviations: RCT: randomised controlled trial, Q-RCT: quasi-randomised controlled trial, PCoSt: prospective comparative study, RCoSt: retrospective comparative study, PCCSt: prospective case-control study, PNCoSt: 
prospective non-comparative study, RNCoSt: retrospective non-comparative study, FSt: follow-up study, PCS: prospective case series, RCS: retrospective case series, BACS: before-after case series, BACR: before-after case report, CR: 
case report. 
Abbreviations: AAOMS: American association of oral and maxillofacial surgery, AC: arthrocentesis, ACL: acute closed lock, ARS: anterior repositioning splint, AS: arthroscopy, CBT: cognitive behavioural therapy, CCL: chronic closed 
lock, Ch: chronic,CL: closed lock, CMI: craniomandibular index, cMMO: comfortable ‘painless’ maximum mouth opening, CS: corticosteroids, Ctrl: control, DAL: daily activity limitation, DDwoR: disc displacement without reduction, DR: 
disc recapturing, drop: drop-outs, dy: day, exc: excluded, Exr: exercises, F: female, GA: general anaesthesia, IAOMS: international association of oral and maxillofacial surgery, ID: internal derangement, IL: intermittent locking, IM: intra-
muscular, ITT: intention-to-treat analysis, IV: intra-venous, j: joint, LA: local anaesthesia, LDF: limitation in daily function, LM: lateral movement, M: male, Med: medication, MFIQ: mandibular function impairment questionnaire, mm: 
millimetres, MMO: maximum mouth opening, mo: month, MR: muscle relaxant, MRI: magnetic resonance imaging, N: number of patients, NR: not reported, NS: non-surgical, NSAIDs: non-steroidal anti-inflammatory drugs, OS: open 
surgery, PM: protrusive movement, PM: pumping manipulation, PS: pivot splint, PT: physiotherapy, Reh: rehabilitation, S&S: signs and symptoms, SD: standard deviation, SG: successful group, SM: self-management, SS: stabilization 
splint, Sub-ac: sub-acute, UG: unsuccessful group, UM: unlock manipulation, VAS: visual analogue scale, W: Wilkes staging of internal derangement, wk: week, yr: year. 
a
 Study data are also provided in other tables according to main treatment modality assessed. 
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Table 3: Characteristics of included splint (± other conservative) therapy studies. 
Study 
(Year) 
Study 
design 
Participants’ characteristics 
Main intervention 
assessed 
Longest 
follow-up 
duration 
(months) 
Success criteria 
Study findings in 
relation to CL 
duration 
Overall 
success 
rate % 
(ITT use) 
Study 
design 
quality 
Sample 
size 
(drop/exc) 
Study 
diagno
sis 
Gender 
Age  
(years) 
Locking duration 
(months) 
M  F  Range Mean Range Mean ± SD 
Choi et al. 
(1994) (171) 
PCS 10 DDwoR - 10 14-55 27 0.75-5 2±1.61 SS + PT 3-4 MMO≥40mm 
DR on MRI is unlikely 
to happen in CCL 
100% IV 
Diracoglu et 
al. (2009) 
(172)
 a
 
Q-RCT 
120 
(10) 
DDwoR 16 
10
4 
15-63 34.1 max. of 0.7 - 
AC, N=54 
SS + PT, N= 56 
6 
Improvement in: VAS 
pain, MMO, LM, & PM 
Both are effective for 
early DDwoR but AC 
is superior for pain 
relief 
- 
(no ITT) 
III-1 
Haketa et al. 
(2010) (145)
 a
 
RCT 
52 
(14) 
DDwoR 6 46 - 37.6 Over 0.5 - 
SS + Self-care, N=25 
Self-care + Self-
exercise, N=19 
2 
Improvement in: VAS 
pain, MMO, & LDF 
- 
- 
(ITT) 
II-1 
Harth (2012) 
(173) 
CR 1 DDwoR - 1 - 53 2 - 
Decompression splint + 
Exercises 
21 cMMO>38mm - - IV 
Ismail et al. 
(2007) (174) 
RCT 26 
21
 b
 
DDwoR 
3 23 - 42.8 Less than 6 - 
SS, N=13 
SS + Exercises, N=13 
3 
Improvement in: pain & 
MMO 
- - II-2 
Israel and 
Syrop (1997) 
(175) 
CRs 2 DDwoR - 2 14-28 - 0.03-0.5 - 
Splint + Self-care/Med 
+ PT  
0.5-12 
No pain, MMO≥35mm, 
eating normal diet, & 
patient satisfaction 
- - IV 
Iwase et al. 
(2005) (131) 
RNCoSt 52 DDwoR 8 44 - 32.1 ≤12 - >12 
25.71±56.1
1 
SS+ Self-Exercises+ 
NSAIDs 
- 
VAS pain≤30,  
cMMO≥30mm, & 
patient satisfaction 
Non-responders: 
80%>12m symptoms’ 
duration & 20%≤12m 
Responders: 
75.7%>12m & 
24.3%≤12m 
71.2% IV 
Kai et al. 
(1998) (71) 
PNCoSt 35 DDwoR - 35 15-63 37.3 0.5-48 4.9 SS 25-42 
Improvement in: pain & 
MMO≥40mm 
- 55.9% III-3 
Kuwahara et 
al. (1990) 
(176) 
PCS 8 
DDwoR 
(Acute) 
- - 13-59 - 0.5-6 - Disc recapturing splint 6-16 MMO>35mm - 100% IV 
Le Bell and 
Forssell 
(1993) (177) 
PCS 
22 
(2) 
DDwoR 5 17 17-68 
Median 
27 
< 1 - <12 - 
SS + OA  
(<1mo, N=15 
<6mo, N=5 
>6mo but <12mo, N=2 ) 
24 
Improvement in: pain & 
jaw movements 
(Helkimo anamnestic & 
dysfunction indices: Ai: 
0 or 1, Di: II)  
- 
95.5% 
(ITT) 
IV 
Lee et al. 
(2013) (178)
 a
 
RCoSt 43 DDwoR 3 40 - 21.9 At least 3 - 
AC + HS & SS, N=17 
SS then AC + HS, 
N=13 
SS only, N=13 
6 
AAOMS criteria: 
VAS pain<30 & 
cMMO≥38mm or 
increase cMMO≥10mm 
- - III-3 
Linde et al. 
(1995) (179) 
RCT 
33 
(2) 
DDwoR 5 26 17-68 
Median 
37 
0.5-192 
Median  
6 
SS, N=16 
TENS, N=15 
1.5 
VAS Pain reduction 
≥50%, MMO≥40mm, 
LM≥7mm, & PM≥7mm 
- 
SS: 53%, 
TENS: 6% 
(no ITT) 
II-2 
Minakuchi et 
al. (2001; 
2004) (166, 
167)
 a
 
RCT 
69 
(8) 
DDwoR 7 62 - 34 - 
3.89±5.56 Education, N=21 
2 
Improvement in: VAS 
pain, MMO, & DAL 
- 
- 
(ITT) 
II-1 
2.81±5.09 
Self-care/NSAIDs, 
N=23 
3.12±5.03 
SS+ Exercises + Self-
care/NSAIDs, N=25 
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Table 3 (Continued): 
Study 
(Year) 
Study 
design 
Participants’ characteristics 
Main intervention 
assessed 
Longest 
follow-up 
duration 
(months) 
Success criteria 
Study findings in 
relation to CL 
duration 
Overall 
success 
rate % 
(ITT use) 
Study 
design 
quality 
Sample 
size 
(drop/exc) 
Study 
diagno
sis 
Gender 
Age  
(years) 
Locking duration 
(months) 
M  F  Range Mean Range Mean ± SD 
Murakami et 
al. (1995)  
(12)
 a
 
PCoSt 108 
W: III 
(CL) 
20 88 - 31.43 - 
5.0±8.8 NS: Med/UM/PS, N=63  
6 
VAS pain<20, MMO>38 
mm, LM & PM> 6mm, 
& improved DAL 
Patients with >7mo 
locking duration did 
not respond to  
arthrocentesis 
NS: 55.6% 
(Md:15.9% 
UM:18.9% 
PS: 33.3%) 
AC: 70% 
AS: 91% 
III-2 
5.6±6.9 AC, N=20 
6.8±10.2 AS, N= 25 
Murakami et 
al. (2002) 
(111) 
FSt
 c
 
63 
(7) 
W: III 
(CL) 
8 42 13- 75 33.2 - 5.0±8.8 
Med (NSAIDs + MR), or 
UM, or PS 
120 
Improvement in: VAS 
pain, Jaw function, & 
DAL 
- 
89.3% 
(ITT) 
IV 
Ohnuki et al. 
(2006) (137)
 a
 
RCoSt 85 DDwoR 9 76 13-73 41.8 - 
5.1±6.8 SS, N=11 
12 
VAS pain<20 & 
MMO>38mm 
No significant 
difference between 
SGs regarding 
duration of locking. 
SS: 12.9% 
PM: 44.6% 
AC: 22% 
AS: 100% 
III-3 
10.4±13.1 PM, N=33 
6.6±8 AC, N=9 
14.2±22.2 AS, N=32 
Schiffman et 
al. (2007; 
2013) (168, 
169) 
a
 
RCT 
108 
(12) 
W: III-
IV 
DDwoR 
8 98 - 31.72 
Non-ch <6 - 
ch≥6 
- 
SM + Med, N=29 
SS + PT + CBT, N=25 
AS + CS, N=26 
OS, N=26 
60 
Self-reported success  
(Patient satisfaction) 
- 
SM: 72% 
Reh: 81% 
AS: 76.2% 
OS: 83.3% 
(ITT) 
II-1 
Shoji (1995) 
(180) 
CR 1 
DDwoR 
Chronic 
- 1 - 16 6 - SS 1.5 
Reduced pain & 
MMO≥35mm 
- - IV 
Stiesch-
Scholz et al. 
(2002) (140) 
PNCoSt 55 DDwoR 7 48 15–77 41.96  <0.25 - >6 - 
PS 
Acute(<3), N=19 
Sub-acute (3–6), N=19 
Chronic (>6), N=17 
45-50 
VAS pain=0, 
MMO≥40mm, improved 
LM, PM, & chewing 
ability 
The success rate of 
treatment decreased 
with longer locking 
duration: acute 
(84.2%), Sub-acute 
(63.2%), & chronic 
(64.7%).  
DR in 3 patients with 
<1wk. 
72.7% III-3 
Stiesch-
Scholz et al. 
(2005) (181) 
RCT 40 DDwoR 5 35 18-64 33.65 - 
3.83±3.45 SS, N=20 
3 
Improvement in: pain, 
MMO, LM, & PM 
- - II-1 
4.68±2.9 PS, N=20 
Tanaka et al. 
(2000) (182) 
CR 1 
W: IV 
DDwoR 
- 1 - 22 60 - Splint + Exercises 60 Improved pain & MMO - - IV 
Yoshida et al. 
(2005) (183) 
PNCoSt 40 DDwoR - 40 16-64 29.85 - 
51.6±57.6 SS-UFD, N=20 
6 
No pain or pain present 
only on jaw movement 
& increased MMO 
- 
Overall: 
57.5% 
UFD: 20% 
DFD: 95% 
III-3 
33.6±39.6 SS-DFD, N=20 
TOTAL 
12studies - DDwoR - - - - 0.25-192 15.53 Splint only - - - 60.1% - 
10studies - DDwoR - - - - - 10.28 Splint + others - - - 84.1% - 
Study Design abbreviations: RCT: randomised controlled trial, Q-RCT: quasi-randomised controlled trial, PCoSt: prospective comparative study, RCoSt: retrospective comparative study, PCCSt: prospective case-control study, PNCoSt: 
prospective non-comparative study, RNCoSt: retrospective non-comparative study, FSt: follow-up study, PCS: prospective case series, RCS: retrospective case series, BACS: before-after case series, BACR: before-after case report, CR: 
case report. 
Abbreviations: AAOMS: American association of oral and maxillofacial surgery, AC: arthrocentesis, ACL: acute closed lock, ARS: anterior repositioning splint, AS: arthroscopy, CBT: cognitive behavioural therapy, CCL: chronic closed 
lock, Ch: chronic, CL: closed lock, CMI: craniomandibular index, cMMO: comfortable ‘painless’ maximum mouth opening, CS: corticosteroids, Ctrl: control, DAL: daily activity limitation, DDwoR: disc displacement without reduction, DFD: 
downward flexure deformation, DR: disc recapturing, drop: drop-outs, dy: day, exc: excluded, Exr: exercises, F: female, GA: general anaesthesia, IL: intermittent locking, IM: intra-muscular, ITT: intention-to-treat analysis, LDF: limitation in 
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daily function, LM: lateral movement, M: male, Med: medication, MFIQ: mandibular function impairment questionnaire, mm: millimetres, MMO: maximum mouth opening, mo: month, MR: muscle relaxant, MRI: magnetic resonance 
imaging, N: number of patients, NR: not reported, NS: non-surgical, NSAIDs: non-steroidal anti-inflammatory drugs, OA: occlusal adjustment, OS: open surgery, PM: protrusive movement, PM: pumping manipulation, PS: pivot splint, PT: 
physiotherapy, Reh: rehabilitation, S&S: signs and symptoms, SD: standard deviation, SG: successful group, SH: sodium hyaluronate, SM: self-management, SS: stabilization splint, Sub-ac: sub-acute, TENS: transcutaneous electrical 
nerve stimulation, UFD: upward flexure deformation, UG: unsuccessful group, UM: unlock manipulation, VAS: visual analogue scale, W: Wilkes staging of internal derangement, wk: week, yr: year. 
a
 Study data are also provided in other tables according to main treatment modality assessed. 
b
 DDwoR patients in study sample ≥ 80%. 
c
 Follow-up report of Murakami et al. (1995) study (12). 
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Table 4: Characteristics of included arthrocentesis (AC) studies. 
Study
 
(Year) 
Study 
design 
Participants’ characteristics 
Main interventions 
assessed 
Longest 
follow-up 
duration 
(months) 
Success criteria 
Study findings in 
relation to CL duration 
% Overall 
success 
rate 
(ITT used) 
Study 
design 
quality 
Sample 
size 
(drop/exc) 
Study 
diagno
sis 
Gender 
Age  
(years) 
Locking duration 
(months) 
M  F  Range Mean Range Mean ± SD 
Aktas et al. 
(2010a) (184) 
PCoSt 25 DDwoR 2 23 17–64 30.4 
 
0.1-24 
 
6.76 
AC alone, N=13 
AC + SH, N=12 
12 
AAOMS criteria: VAS 
pain≤30mm, MMO 
≥35mm, & improved 
jaw function 
Mean locking duration 
was higher in UG 9.6 (1–
24) than SG 3.92 (0.1-24) 
Overall 80% 
AC:84.6%, 
AC+SH: 
75% 
III-2 
Aktas et al. 
(2010b) (185) 
RCT 21 DDwoR 4 17 15-52 26.43 0.1–24 5.29 
AC alone, N= 14 
AC + TX., N= 7 
6 
AAOMS criteria: VAS 
pain≤30mm, MMO 
≥35mm, improved 
jaw function 
- 
Overall 
83.3% 
AC:85.7%,  
AC+TX: 
71.4% 
II-2 
Alpaslan and 
Alpaslan 
(2001) (187) 
RCT 15
 a
 
DDwoR 
(CL) 
1 14 15-53 31.90 2-72 18.5 
AC alone, N=4 
AC + SH, N=11 
3-28 
Improvement in: 
pain, MMO, LM, & 
jaw function 
- - II-2 
Alpaslan et al. 
(2008) (186) 
RCT 
67 
(12) 
DDwoR - - 18-51 30.1 0.03-18 6.73 
AC alone, N=14 
AC + soft splint, N=9 
AC + hard splint, 
N=22 
6 
Improvement in: 
pain, MMO, & LM 
- 
- 
(no ITT) 
II-2 
Bhargava et 
al. (2012) 
(188) 
CR 1 DDwoR - 1 - 32 3 - AC + CS 1 
MMO≥35mm & VAS 
pain=0 
- - IV 
Dhaif and Ali 
(2001) (189) 
RNCoSt 
62 
(22) 
ADP 9 53 16-50 28.9 0.75-12 11.43±8.35 AC, N=40 36 
VAS pain<2, 
MMO≥38mm, 
LM≥5mm, PM≥5mm, 
improved DLA 
- 95% IV 
Dimitroulis et 
al. (1995) 
(190) 
FSt
 b
 46 ADP 2 44 25-39 32.5 1-84 13 AC 6-30 
Improvement in: VAS 
pain, VAS jaw 
dysfunction (chewing 
ability), & MMO 
- 97.8%  IV 
Diracoglu et 
al. (2009) 
(172)
 c
 
Q-RCT 
120 
(10) 
DDwoR 16 104 15-63 34.1 
max. of 
0.7 
- 
AC, N=54 
SS + PT, N= 56 
6 
Improvement in: VAS 
pain, MMO, LM, & 
PM 
Both are effective for 
early DDwoR but AC is 
superior for pain relief 
- 
(no ITT) 
III-1 
Emshoff and 
Rudisch 
(2004) (192)
 d
 
PNCoSt 29 
DDwoR 
(ID III) 
7 22 17-69 34.6 
Non-
ch≤6-
Ch>6<24 
8.76 
AC 
(Non-chronic, N=15 
Chronic, N=14) 
2 
Absence of DDwoR 
S&S and 
VAS Pain 
Reduction≥85% 
Symptoms’ duration was 
lower in SG (5.28±4.03) 
than in UG (12.23±6.83). 
37.9% III-3 
Emshoff and 
Rudisch 
(2007) (193)
 d
 
PNCoSt 37 
DDwoR 
(ID III) 
6 31 17-69 28.3 - 8.68±6.9 AC 2 
MMO≥35 mm & pain 
reduction >50% 
No statistical significant 
difference in duration of 
symptoms between SG 
(9.25±5.53) and UG 
(7.95±8.5). 
56.8% III-3 
Emshoff et al. 
(2000) (194)
 d
 
PNCoSt 15 
DDwoR 
(ID III) 
- 15 18-71 38.7 1-9 5.7 AC 2 
Improvement in: VAS 
pain & MMO 
- - III-3 
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Table 4 (Continued): 
Study 
(Year) 
Study 
design 
Participants’ characteristics 
Main intervention 
assessed 
Longest 
follow-up 
duration 
(months) 
Success criteria 
Study findings in 
relation to CL duration 
Overall 
success 
rate % 
(ITT use) 
Study 
design 
quality 
Sample 
size 
(drop/exc) 
Study 
diagno
sis 
Gender 
Age  
(years) 
Locking duration 
(months) 
M  F  Range Mean Range Mean ± SD 
Emshoff et al. 
(2003) (195)
 d
 
PNCoSt 38 
DDwoR 
(ID III) 
6 32 17-69 33.8 - 7.13±6.1 AC 2 
Absence of DDwoR 
symptoms (VAS pain 
& MMO) 
No statistical significant 
difference in duration of 
symptoms between SG 
(7.38±5.78) and UG 
(6.68±6.8). 
63.2% III-3 
Emshoff 
(2005) (130)
 d
 
PNCoSt 64 
DDwoR 
(ID III) 
6 58 17-69 33.4 
Non-ch 
≤6 - ch>6 
12.31 AC 2 
Absence of DDwoR 
symptoms (VAS pain 
& MMO) 
The mean duration of 
symptoms was lower in 
SG (10.15±9.35) than UG 
(14.48±21.25) but the 
difference was not 
statistically significant. 
53.1% III-3 
Emshoff et al. 
(2006) (191)
 d
 
PNCoSt 28 
DDwoR 
(ID III) 
8 20 17-69 30.9 
Less than 
12 
- AC 2 
Improvement in: VAS 
Pain on jaw function 
& MMO 
- - III-3 
Gateno 
(1994) (196)
 c
 
CRs 2 
DDwoR 
(ACL) 
- 2 25-31 - 0.5-0.7 - AC 3 
MMO≥38mm & VAS 
pain≤4 
- - IV 
Ghanem 
(2011) (197) 
PCoSt 20 
DDwoR 
(ACL) 
- 20 24-54 34 
Less than 
1 
- 
AC + CS, N=10 
AC + CS & SS, N=10 
12 
Improvement in: VAS 
Pain, MMO, LM, PM, 
& jaw dysfunction 
AC+SS are the treatment 
of choice for ACL (<1mo) 
with bruxism 
Overall: 
60%  
AC: 30%  
AC+SS: 
90%  
III-2 
Hosaka et al. 
(1996) (198) 
FSt
 e
 
20 
(1) 
W: III 
(CL) 
- - - 31.2 - 5.6±6.9 AC 36 
VAS pain<2, MMO> 
38mm, LM>6mm, 
PM>6mm, normal 
diet & improved jaw 
function, daily 
activity. 
- 78.9% IV 
Kaneyama et 
al. (2007b) 
(57) 
PCS 14 ADP 5 9 15-70 34.3 0.5-12 4±4.1 AC 1-12 
No or mild pain, 
MMO>38mm, eating 
normal diet 
Symptoms’ duration was 
longer in SG (0.5-12) than 
UG (1-4). 
64.3% IV 
Kaneyama et 
al. (2007a) 
(200) 
PNCoSt 66 DDwoR 4 62 14-73 36 1-24 2 
 
AC + CS 
 
2-13 
No or mild VAS pain, 
MMO>38mm, 
LM>6mm, & 
PM>6mm 
- 77% III-3 
Kaneyama et 
al. (2004) 
(199) 
PCS 17 DDwoR 5 12 17-76 40 0.8-60 19 AC + CS 3 
No or mild VAS pain, 
MMO>38mm, 
LM>6mm, & 
PM>6mm 
No correlation between 
duration of symptoms and 
clinical symptoms  
88% IV 
Lee et al. 
(2013) (178)
 c
 
RCoSt 43 DDwoR 3 40 - 21.9 At least 3 - 
AC + HS & SS, N=17 
SS then AC + HS, 
N=13 
SS only, N=13 
6 
AAOMS criteria: 
VAS pain<30 & 
cMMO≥38mm or 
increase 
cMMO≥10mm 
- - III-3 
Mohanavalli 
et al. (2011) 
(201) 
CR 1 CL - 1 - 28 
More than 
12 
- AC + CS 9 
VAS pain=0, 
MMO≥40 mm, LM & 
PM≥ 6mm, & 
improved function 
- - IV 
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Table 4 (Continued): 
Study 
(Year) 
Study 
design 
Participants’ characteristics 
Main intervention 
assessed 
Longest 
follow-up 
duration 
(months) 
Success criteria 
Study findings in 
relation to CL duration 
Overall 
success 
rate % 
(ITT use) 
Study 
design 
quality 
Sample 
size 
(drop/exc) 
Study 
diagno
sis 
Gender 
Age  
(years) 
Locking duration 
(months) 
M  F  Range Mean Range Mean ± SD 
Murakami et 
al. (1995)  
(12)
 c
 
PCoSt 108 
W: III 
(CL) 
20 88 - 31.43 - 
5.0±8.8 
NS: Med. or UM or 
PS, N=63  
6 
VAS pain<20, 
MMO>38 mm, LM & 
PM> 6mm, & 
improved DAL 
Patients with >7mo 
locking duration not 
respond to AC 
NS: 55.6% 
(Md:15.9% 
UM:18.9% 
PS: 33.3%) 
AC: 70% 
AS: 91% 
III-2 
5.6±6.9 AC, N=20 
6.8±10.2 AS, N= 25 
Ness and 
Crawford 
(1996) (202) 
RCS 15 CL - - - - 
0.23–1 0.6 ACL AC +CS 
(ACL<4 mo, N=6 
CCL>4 mo, N=9) 
- 
MMO >40 mm, no or 
mild pain, and normal 
eating 
- 64% IV 
4–109 38.1 CCL 
Nishimura et 
al. (2001; 
2004) (203, 
204) 
PNCoSt 100 
95
 f
 
DDwoR 
11 89 13-73 
Median 
31 
0.07-36 5.67 
 
 
AC + CS 
 
 
0.25 
No or mild VAS pain 
& MMO>38mm 
The mean duration of 
locking was lower in SG 
4.33 (0.033-36.5) than 
UG 8.43 (0.13-36.7) but 
the difference was not 
statistically significant. 
70.9% III-3 
Nitzan et al. 
(1991) (206) 
PCS 17 ADP 3 14 16-65 32.6 2-60 11.8±12.9 AC + CS 4-14 
VAS pain≤4 of 15, 
VAS jaw 
dysfunction≤4 of 15, 
MMO≥35mm, PM & 
LM>7mm, & patient 
satisfaction  
One patient with longest 
duration of symptoms (60 
mo) showed marked 
increase in MMO but no 
significant decrease in 
pain & jaw dysfunction. 
91% IV 
Nitzan (1994) 
(205) 
PCS 29 ADP 8 21 - - - 13.9 AC + CS 
Mean  
22.2 
Improvement in: VAS 
Pain, VAS jaw 
dysfunction, & MMO 
- 96.5% IV 
Nitzan et al. 
(1997) (55) 
PNCoSt 39 ADP 8 31 14-53 28.9 0.5-48 11.43±8.35 AC 6-37 
Improvement in: VAS 
Pain & VAS jaw 
dysfunction, 
MMO≥35mm, PM & 
LM≥5mm, & patient 
satisfaction 
Increased duration of 
symptoms seemed to 
affect joint function and 
deteriorate it. 
95% III-3 
Ohnuki et al. 
(2006) (137)
 c
 
RCoSt 85 DDwoR 9 76 13-73 41.8 - 
5.1±6.8 SS, N=11 
12 
VAS pain<20 & 
MMO>38mm 
No significant difference 
between SGs regarding 
locking duration. 
SS: 12.9% 
PM: 44.6% 
AC: 22% 
AS: 100% 
III-3 
10.4±13.1 PM, N=33 
6.6±8 AC, N=9 
14.2±22.2 AS, N=32 
Sahlstrom et 
al. (2013) 
(207) 
RCT 
45 
(8) 
DDwoR 4 41 - 34.9 ≤3 - 
LA only, N=25 
AC, N=20 
3 
Reduction in VAS 
pain≥30% during jaw 
movement 
- 
LA: 76% 
AC: 55%  
(ITT) 
II-1 
Sakamoto et 
al. (2000) 
(138) 
PCS 18 DDwoR 1 17 17-67 33.3 2.3-46 14±12.8 AC 3 
AAOMS criteria: 
MMO≥40mm & VAS 
pain<33 
Symptoms’ duration in 
SG (8.4±5.4) was 
significantly shorter than 
in UG (19.6±15.6). 
50% IV 
Sanroman 
(2004) (58)
 c
 
PCoSt 
26 
(2)  
ADP 6 20 16-35 24.3 0.23-3 1.21 
AS + SH, N=16 
AC + SH, N=8 
24-36 
VAS pain≤ 2 of 15, 
MMO≥35mm,  
LM≥7mm 
& PM≥10mm  
- 100% III-2 
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Table 4 (Continued): 
Study 
(Year) 
Study 
design 
Participants’ characteristics 
Main intervention 
assessed 
Longest 
follow-up 
duration 
(months) 
Success criteria 
Study findings in 
relation to CL duration 
Overall 
success 
rate % 
(ITT use) 
Study 
design 
quality 
Sample 
size 
(drop/exc) 
Study 
diagno
sis 
Gender 
Age  
(years) 
Locking duration 
(months) 
M  F  Range M  F  Range 
Sato et al. 
(1997) (210) 
PCoSt 76 DDwoR 2 74 11-74 29.9 
0.1-60 5.9 Pumping SH
 g
, N= 26 
6 
AAOMS Criteria: little 
or no pain, MMO≥35 
mm, LM or PM> 
4mm, eating normal 
diet & improved jaw 
function. 
- 
P-SH: 
73.1% 
Ctrl:36% 
III-2 
0.1-48 6.5 No treatment, N=50 
Sato et al. 
(2001) (208) 
RCoSt 
146 
(25) 
DDwoR 9 107 - - 3> - 3≤ - 
Pumping SH
 g
, N= 
59/72 
No treatment, N= 
62/74 
12 
AAOMS Criteria: 
 Little/no pain & 
MMO≥35mm 
Patients with locking 
duration for <3 mo are 
more likely to benefit from 
treatment than those with 
locking duration for ≥3 m. 
P-SH: 75% 
Ctrl: 63.5% 
(ITT) 
III-3 
Sato and 
Kawamura 
(2008) (209) 
PCoSt 59 DDwoR - 59 13-61 34.95 
0.2-336 31.6 
Pumping SH
 g
 + Self-
exercises, N=23 
12 
AAOMS Criteria: 
 Little/no pain, 
MMO≥35mm 
- 
Overall: 
69.49% 
P-SH+ Ex: 
60.9% 
P-SH only: 
75% 
III-2 
0.03-440 36.4 Pumping SH, N=36 
Sembronio et 
al. (2008) (13) 
PNCoSt 33 DDwoR 2 31 21-73 41.8 0.25-24 8.5 
AC + SH + UM 
(ACL<1, N=8  
CCL>1, N=25) 
12 
VAS pain< 2, 
MMO >38 mm, ADL 
<4/16, & improved 
jaw function, chewing 
& swallowing, & 
eating normal diet  
Higher success rate in 
ACL (87.5%) than CCL 
(68%). DR was possible 
only in ACL and no DR in 
all CCL cases. 
72.7% III-3 
Thomas et al. 
(2012) (211) 
PCS 32 ACL 5 27 18-27 23 1-3 - AC 6 
Improvement in: VAS 
pain, VAS jaw 
dysfunction (chewing 
ability), & MMO. 
- 90.6% IV 
Yura et al. 
(2011) (143) 
PNCoSt 50 
DDwoR 
(CCL) 
5 45 12-71 
Median 
44 
3-48 
Median 
4 
AC (under high 
pressure) + CS 
2 
Improvement in: 
MMO≥40mm, VAS 
pain at 
opening≤5mm, & 
VAS pain on biting=0 
- - III-3 
TOTAL 
32studies - All CL - - - - 0.03-109 9.49 AC - - - 72.5% - 
27studies - DDwoR - - - - 0.03-109 10 AC - - - 65.2% - 
7studies - ADP - - - - 0.23-84 9.54 AC - - - 91.4% - 
Study Design abbreviations: RCT: randomised controlled trial, Q-RCT: quasi-randomised controlled trial, PCoSt: prospective comparative study, RCoSt: retrospective comparative study, PCCSt: prospective case-control study, PNCoSt: 
prospective non-comparative study, RNCoSt: retrospective non-comparative study, FSt: follow-up study, PCS: prospective case series, RCS: retrospective case series, BACS: before-after case series, BACR: before-after case report, CR: 
case report. 
Abbreviations: AAOMS: American association of oral and maxillofacial surgery, AC: arthrocentesis, ACL: acute closed lock, ADP: anchored disc phenomenon, ARS: anterior repositioning splint, AS: arthroscopy, CCL: chronic closed lock, 
Ch: chronic, CMI: craniomandibular index, cMMO: comfortable ‘painless’ maximum mouth opening, CS: corticosteroids, Ctrl: control, DAL: daily activity limitation, DDwoR: disc displacement without reduction, DLA: daily living activity, DR: 
disc recapturing, drop: drop-outs, dy: day, exc: excluded, Exr: exercises, F: female, GA: general anaesthesia, IAOMS: international association of oral and maxillofacial surgery, ID: internal derangement, IL: intermittent locking, ITT: 
intention-to-treat analysis, j: joint, LA: local anaesthesia, LDF: limitation in daily function, LM: lateral movement, M: male, Med: medication, MFIQ: mandibular function impairment questionnaire, mm: millimetres, MMO: maximum mouth 
opening, mo: month, MRI: magnetic resonance imaging, N: number of patients, NR: not reported, NS: non-surgical, NSAIDs: non-steroidal anti-inflammatory drugs, OS: open surgery, PM: protrusive movement, PM: pumping manipulation, 
PS: pivot splint, P-SH: pumping sodium hyaluronate, PT: physiotherapy, S&S: signs and symptoms, SD: standard deviation, SG: successful group, SH: sodium hyaluronate, SM: self-management, SS: stabilization splint, Sub-ac: sub-
acute, Tx: tenoxicam, UG: unsuccessful group, UM: unlock manipulation, VAS: visual analogue scale, W: Wilkes staging of internal derangement, wk: week, yr: year. 
a
 Separate data provided are for CL patients only. 
b
 Follow-up report of Nitzan and Dolwick (1991) study (9). 
c
 Study data are also provided in other tables according to main treatment modality assessed. 
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d
 Studies seem to share part of their CL study sample in multiple publications. 
e
 Follow-up study of Murakami et al. (1995) study (12). 
f
 DDwoR patients in study sample ≥ 80%. 
g
 Excluded from the total due to intervention difference. 
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Table 5: Characteristics of included arthroscopy (AS) studies. 
Study
 
(Year) 
Study 
design 
  Participants’ characteristics 
Main interventions 
assessed 
Longest 
follow-up 
duration 
(months) 
Success criteria 
Study findings in 
relation to CL duration 
Overall 
success 
rate % 
(ITT used) 
Study 
design 
quality 
Sampl
e size 
(drop/ex
c) 
Study 
diagnosi
s 
Gender 
Age  
(years) 
Locking duration 
(months) 
M F Range Mean Range Mean ± SD 
Casares et al. 
(1999) (59) 
PNCoSt 26 
ADP 
(static 
disc) 
- 26 20-56 37.5 3-24 7.8 AS 10 
Pain free & 
MMO>30mm  
A relationship between 
CL duration and 
adhesions type was found  
92.3% III-3 
Chen et al. 
(2010) (212) 
PCS 352 
W: III-IV 
343/419 j
a
 
50 302 15-72 33.3 2-240 24.1 
AS coblation with disc 
suturing 
3 
Improvement in 
S&S and MRI 
findings   
- 92.8% IV 
Clark et al. 
(1991) (213) 
PNCoSt 18 
17 
DDwoR 
& 1 ADP 
1 17 15-52 27 
Sub-ac 
=3-9 to 
ch>9 
12.4±12 AS 21-30 
Improvement in: 
VAS pain, jaw 
function, & MMO 
Locking duration was not 
a predictor of AS success 
or failure. 
83.3% III-3 
Dimitroulis 
(2002) (120) 
PCS 56  
49 
DDwoR 
9 47 15-70 36 1.5-12 3.4 AS + CS 1.5 
Improvement in: 
VAS pain, MMO, & 
patient satisfaction 
- 66% IV 
Furst et al. 
(2001) (214) 
RCT 32 
26 
DDwoR 
2 30 - - - 
42.5±36.1 AS only 
0.07 Pain reduction - - II-2 
18.5±17 AS + bupivacaine 
61.4±61.3 AS + morphine 
63.3±79.7 
AS + bupivacaine & 
morphine 
Gateno 
(1994) (196) 
b
 
CR 1 CL - 1 - 24 3 - AS - 
No pain & 
MMO>40mm 
- - IV 
Go et al. 
(1996) (215) 
PCS 10 CL - 10 20-59 31.2 0.75-3.75 2.2 AS 4-68 
No or mild pain & 
MMO>30mm 
- 80% IV 
Hamada et al. 
(2003) (218)
 c
 
PNCoSt 
69 
(39) 
DDwoR 
(CCL) 
5 25 20-64 41.6 1-72 15.5 
AS (2
nd
 VGIR) + SH, 
N=30 
- 
VAS pain<20 & 
<60% of 
preoperative level, 
increased cMMO, 
& cMMO≥38mm 
- 
60% 
(no ITT) 
III-3 
Hamada et al. 
(2005) (217)
 c
 
PNCoSt 
68 
(20) 
DDwoR 
(CCL) 
9 39 20–70 42.8 2–127 
Median 
9.5 
AS (2
nd
 VGIR), N=48 3–36 
VAS pain=0 & 
cMMO≥38mm 
No significant correlation 
between duration of 
symptoms and treatment 
outcome with fibrous 
adhesion. 
62.5% 
(no ITT) 
III-3 
Hamada et al. 
(2006a) 
(219)
c
 
PNCoSt 
64  
(3) 
DDwoR 
(CCL) 
9 52 19-70 40.7 2-127 
Median 
7 
AS (1
st
 VGIR), N=64 12 
VAS pain<20 & 
<60% of 
preoperative level, 
increased cMMO, 
& cMMO≥38mm 
No significant difference 
in the duration of 
symptoms between SG 8 
(2-108) and UG 5 (2-127). 
72.1% 
(no ITT) 
III-3 
Hamada et al. 
(2006b) 
(106)
c
 
PNCoSt 
36 
(2)  
DDwoR 
(CCL) 
6 30 27-59 46.5 
IQ 
3–17 
Median  
7.5 
AS (VGIR), N=36 - 
VAS pain<20 & 
<60% of 
preoperative level, 
increased cMMO, 
& cMMO≥38mm 
No significant difference 
in the duration of 
symptoms between SG 8 
(5.5–17) and UG 6 (3–8). 
69.4% 
(no ITT) 
III-3 
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Table 5 (Continued): 
Study
 
(Year) 
Study 
design 
Participants’ characteristics 
Main interventions 
assessed 
Longest 
follow-up 
duration 
(months) 
Success criteria 
Study findings in 
relation to CL duration 
Overall 
success 
rate % 
(ITT used) 
Study 
design 
quality 
Sampl
e size 
(drop/ex
c) 
Study 
diagnosi
s 
Gender 
Age  
(years) 
Locking duration 
(months) 
M F Range Mean Range Mean ± SD 
Hamada et al. 
(2008a; 
2008b) (216, 
220)
 c
 
PNCoSt 
58 
(2) 
DDwoR 
(CCL) 
8 48 29-56 
Median 
46 
IQ 
3-12.5 
Median  
7 
AS (1
st
 VGIR), N=56 6-13 
VAS pain<20 & 
<60% of 
preoperative level, 
increased cMMO, 
& cMMO≥38mm 
No significant difference 
in duration of symptoms 
between SG 8 (5.8–12.3) 
and UG 6 (3–8). 
67.9% 
(no ITT) 
III-3 
Holmlund et 
al. (2001) 
(121) 
RCT 
22 
(2) 
CCL 2 18 22–53 34.5 
2-24 8.5 OS, N=10 
12 
VAS pain<20, 
MMO>35mm, 
PM>5mm, 
MFIQ<7  
No difference in 
improvement between 
patients having <6 mo & 
>6 mo symptoms’ 
duration in both groups. 
OS: 70%, 
AS: 50% 
(no ITT) 
II-2 
2–60 20.5 AS, N=10 
Kim et al. 
(2009) (221) 
PCS 15 DDwoR 3 12 15-64 32.1 3-72 21.4 AS (ultrathin) + SH 10-40 
VAS pain ≤20 & 
<60% of 
preoperative level, 
increased 
MMO≥5mm, & no 
recurrence of 
symptoms.  
- 80% IV 
Kondoh et al. 
(2003a) 
(222)
c
 
PNCoSt 20 DDwoR 4 16 20-69 44 1-72 17.4 AS (VGIR) + SH 6 
VAS pain<20 & 
<60% of 
preoperative level, 
& cMMO>38mm  
- 80% III-3 
Kumagai et 
al. (2010) 
(223)
 c
 
PNCoSt 45 
DDwoR 
(CCL) 
13 32 24-65 36.5 
More than 
3 
- AS (VGIR), N=45 2-23 
VAS pain <20 and 
<60% of 
preoperative level, 
& cMMO≥38mm 
- 71.1% III-3 
Kurita et al. 
(1998) (134) 
PNCoSt 14 DDwoR 1 13 20-72 44.6 9-163 24.9 AS + CS 13–66 
AAOMS & IAOMS 
criteria: No or 
slight dysfunction 
(MMO≥35mm, 
VAS≤33) 
No difference in locking 
duration between SG 27 
(9-163) & UG 10 & 14 mo. 
85.7% III-3 
Lewis (1987) 
(224) 
CR 1 
DDwoR 
(CCL) 
- 1 - 48 12 - AS 0.25 
Little pain & 
MMO=35mm 
- - IV 
Machon et al. 
(2012) (225) 
PNCoSt 50 
Chronic 
DDwoR 
- - - - 
(<12 - 
>12) 
- 
AS, N=50 
(<12 mo, N=28; 
>12 mo, N= 22) 
6 
No or minimal pain 
(0 or 1 out 6), & 
MMO>35mm 
Higher success rate 
(89%) in patients with 
shorter duration of 
symptoms <12 mo than 
the rate (72%) in those 
with longer symptoms’ 
duration >12 mo. 
82% III-3 
Murakami 
(1990) (226) 
PCS 32 DDwoR 4 28 14-70 39 1-18 6.6 AS 2-60 
Little or no 
complaints and 
good jaw opening 
& function 
Patients with ≥6 mo 
locking duration had poor 
response to AS. Higher 
pain relief in patients with 
<6mo symptoms’ duration 
as compared to patients 
with longer duration. 
84.4% IV 
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Table 5 (Continued): 
Study
 
(Year) 
Study 
design 
Participants’ characteristics 
Main interventions 
assessed 
Longest 
follow-up 
duration 
(months) 
Success criteria 
Study findings in 
relation to CL duration 
Overall 
success 
rate % 
(ITT used) 
Study 
design 
quality 
Sampl
e size 
(drop/ex
c) 
Study 
diagnosi
s 
Gender 
Age  
(years) 
Locking duration 
(months) 
M F Range Mean Range Mean ± SD 
Murakami et 
al. (1995)  
(12)
 b
 
PCoSt 108 
W: III 
(CL) 
20 88 - 31.43 - 
5.0±8.8 
NS: Med. or UM or PS, 
N=63  
6 
VAS pain<20, 
MMO>38 mm, LM 
& PM> 6mm, & 
improved DAL 
Patients with >7mo 
locking duration not 
respond to AC 
NS: 55.6% 
(Md:15.9% 
UM:18.9% 
PS: 33.3%) 
AC: 70% 
AS: 91% 
III-2 5.6±6.9 AC, N=20 
6.8±10.2 AS, N= 25 
Nakaoka et 
al. (2009) 
(227) 
PNCoSt 
56 
(16) 
CCL - - 
IQ 
29–55 
Median 
43 
IQ 
5–12 
median 
7 
AS (2
nd
 VGIR), N=40 - 
VAS pain<20 & 
<60% of 
preoperative level, 
increased cMMO, 
& cMMO≥38mm 
No significant difference 
in symptoms’ duration 
between SG 8 (5.5–12.5) 
& UG 5 (3–12). 
72.5% 
(no ITT) 
III-3 
Nitzan et al. 
(1990) (228) 
PCS 20 8 DDwoR - 20 19-40 26.3 6-96 34.8±26.04 AS + CS 6-24 
Improvement in: 
VAS Pain, VAS 
jaw dysfunction, & 
MMO 
- 
DDwoR  
87.5% 
IV 
Ohnuki et al. 
(2003) (229) 
RNCoSt 43 
40 
DDwoR 
4 39 15-68 41.4 - 12.6±20.1 AS + CS + SH 12 
VAS pain<20 & 
MMO>38mm  
No statistically significant 
difference in locking 
duration between SG 
(14.2±22.2) and UG 
(7.9±11.4). 
74.4% IV 
Ohnuki et al. 
(2006) (137)
 b
 
RCoSt 85 DDwoR 9 76 13-73 41.8 - 
5.1±6.8 SS, N=11 
12 
VAS pain<20 & 
MMO>38mm 
No significant difference 
between SGs regarding 
locking duration. 
SS: 12.9% 
PM: 44.6% 
AC: 22% 
AS: 100% 
III-3 
10.4±13.1 PM, N=33 
6.6±8 AC, N=9 
14.2±22.2 AS, N=32 
Politi et al. 
(2007) (230)
 b
 
RCT 20 
DDwoR 
(CCL) 
6 14 25-67 42.8 
6-27 15.1 OS , N=10 
12 
VAS pain≤20, 
MMO≥35mm, 
PM>5mm, 
MFIQ ≤ 7  
- 
OS: 80%, 
AS: 70% 
II-2 
8-24 14.7 AS + SH, N=10 
Saitoa et al. 
(2010) (231) 
PNCoSt 
64 
(3) 
CCL 9 52 19-70 40.7 2-127 
Median 
7 
AS (VGIR) 3-40 
VAS pain<20 & 
<60% of 
preoperative level, 
& cMMO≥38mm  
No statistically significant 
difference in locking 
duration between SG 8 
(2-108) and UG 5 (2-127).  
72.1% 
(no ITT) 
III-3 
Sanders 
(1986) (232) 
PCS 21
 d
 DDwoR 1 20 11-49 27.1 1-120 19.62±24.2 AS + CS 7-10 
Little pain & 
improved MMO 
- 95.2% IV 
Sanroman 
(2004) (58)
 b
 
PCoSt 
26 
(2)  
ADP 6 20 16-35 24.3 0.25-3 1.21 
AS + SH, N=16 
AC + SH, N=8 
24-36 
VAS pain≤ 2 of 15, 
MMO≥35mm,  
LM≥7mm 
& PM≥10mm  
- 100% III-2 
Schiffman et 
al. (2007; 
2013) (168, 
169)
 b
 
RCT 
108 
(12) 
W: III-IV 
(DDwoR) 
8 98 - 31.72 
Non-ch<6 
- Ch≥6 
- 
SM + Med., N=29 
SS + PT + CBT, N=25 
AS + CS, N=26 
OS, N=26 
60 
Self-reported 
success  
(Patient 
satisfaction) 
- 
SM: 72% 
Reh: 81% 
AS: 76.2% 
OS: 83.3% 
(ITT) 
II-1 
Yoshida et al. 
(2008) (233) 
PCS 55 DDwoR - - - - 2-10.5 4.25 AS (thin fiber & laser) 3 
Improvement in: 
VAS pain, MMO, & 
patient satisfaction. 
- 94.5% IV 
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Table 5 (Continued): 
Study
 
(Year) 
Study 
design 
Participants’ characteristics 
Main interventions 
assessed 
Longest 
follow-up 
duration 
(months) 
Success criteria 
Study findings in 
relation to CL duration 
Overall 
success 
rate % 
(ITT used) 
Study 
design 
quality 
Sampl
e size 
(drop/ex
c) 
Study 
diagnosi
s 
Gender 
Age  
(years) 
Locking duration 
(months) 
M F Range Mean Range Mean ± SD 
Zhang et al. 
(2009) (234) 
RNCoSt 1506 
W: III-IV 
1479
 a
 
28
1 
1225 12–73 29.79 0.5-96 6.97 
AS  
Adhesion group, 
N=490 
Non-adhesion group, 
N=1230 
- - 
Locking duration was 
significantly higher in 
adhesion (6.97±8.38) 
than non-adhesion 
(5.42±4.34) group. 
- IV 
TOTAL 
32studies - All CL - - - - 0.25-163 19.04 AS - - - 79% - 
30studies - DDwoR - - - - 0.5-163 20.37 AS - - - 77.7% - 
2studies - ADP - - - - 0.25-24 4.51 AS - - - 96.2% - 
Study Design abbreviations: RCT: randomised controlled trial, Q-RCT: quasi-randomised controlled trial, PCoSt: prospective comparative study, RCoSt: retrospective comparative study, PCCSt: prospective case-control study, PNCoSt: 
prospective non-comparative study, RNCoSt: retrospective non-comparative study, FSt: follow-up study, PCS: prospective case series, RCS: retrospective case series, BACS: before-after case series, BACR: before-after case report, CR: 
case report. 
Abbreviations: AAOMS: American association of oral and maxillofacial surgery, AC: arthrocentesis, ACL: acute closed lock, ADP: anchored disc phenomenon, ARS: anterior repositioning splint, AS: arthroscopy, CBT: cognitive 
behavioural therapy, CCL: chronic closed lock, Ch: chronic, CMI: craniomandibular index, cMMO: comfortable ‘painless’ maximum mouth opening, CS: corticosteroids, Ctrl: control, DAL: daily activity limitation, DDwoR: disc displacement 
without reduction, DR: disc recapturing, drop: drop-outs, dy: day, exc: excluded, Exr: exercises, F: female, GA: general anaesthesia, ID: internal derangement, IL: intermittent locking, IQ: interquartile, ITT: intention-to-treat analysis, j: joint, 
LA: local anaesthesia, LDF: limitation in daily function, LM: lateral movement, M: male, Med: medication, MFIQ: mandibular function impairment questionnaire, mm: millimetres, MMO: maximum mouth opening, mo: month, MRI: magnetic 
resonance imaging, N: number of patients, NR: not reported, NS: non-surgical, NSAIDs: non-steroidal anti-inflammatory drugs, OA: occlusal adjustment, OS: open surgery, PM: protrusive movement, PM: pumping manipulation, PS: pivot 
splint, PT: physiotherapy, Reh: rehabilitation, S&S: signs and symptoms, SD: standard deviation, SG: successful group, SH: sodium hyaluronate, SM: self-management, SS: stabilization splint, Sub-ac: sub-acute, UG: unsuccessful group, 
UM: unlock manipulation, US: ultrasound, VAS: visual analogue scale, VGIR: visually guided irrigation, W: Wilkes staging of internal derangement, wk: week, yr: year. 
a
 DDwoR patients in study sample ≥ 80%. 
b
 Study data are also provided in other tables according to main treatment modality assessed. 
c
 Studies seem to share part of their CL study sample in multiple publications. 
d
 Separate data provided are for CL patients only. 
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Table 6: Characteristics of included open surgery (OS) studies. 
Study
 
(Year) 
Study 
design 
  Participants’ characteristics 
Main interventions 
assessed 
Longest 
follow-up 
duration 
(months) 
Success criteria 
Study findings in 
relation to CL 
duration 
Overall 
success 
rate % 
(ITT) 
Study 
design 
quality 
Sampl
e size 
(drop/ex
c) 
Study 
diagnosi
s 
Gender 
Age  
(years) 
Locking duration 
(months) 
M F Range Mean Range Mean ± SD 
Holmlund et 
al. (2001) 
(121)
 b
 
RCT 
22 
(2) 
CCL 2 18 22–53 34.5 
2-24 8.5 OS (Discectomy), N=10 
12 
VAS pain<20, 
MMO>35mm, 
PM>5mm, 
MFIQ<7  
No difference in 
improvement 
between patients 
having <6mo & >6mo 
symptoms’ duration 
in both groups. 
OS: 70%, 
AS: 50% 
(no ITT) 
II-2 
2–60 20.5 AS, N=10 
Kondoh et al. 
(2003b) (235) 
PCS  7
 a
 
DDwoR 
(CL) 
- 7 20-51 32.57 14-42 24.57±9.22 
Disc Reshaping without 
repositioning 
60 
Improvement in: pain 
& MMO 
- 
DDwoR 
100% 
IV 
Ozkan et al. 
(2012) (236) 
RNCoSt 46
 a
 
Uni/bilat. 
DDwoR 
8 38 18-63 34.7 - 22.9 
High condylectomy ± disc 
repositioning, discectomy, 
or osteoplasty. 
18-156 
Improvement in: 
pain, MMO, & 
Patient satisfaction 
- - IV 
Politi et al. 
(2007) (230)
 b
 
RCT 20 
DDwoR 
(CCL) 
6 14 25-67 42.8 
6-27 15.1 
OS (High condylectomy & 
disc repositioning), N=10 
12 
VAS pain≤20, 
MMO≥35mm, 
PM>5mm, 
MFIQ ≤ 7  
- 
OS: 80%, 
AS: 70% 
II-2 
8-24 14.7 AS + SH, N=10 
Schiffman et 
al. (2007; 
2013) (168, 
169)
 b
 
RCT 
108 
(12) 
DDwoR 
(W: III-IV) 
8 98 - 31.72 
Non-
ch<6 - 
ch≥6 
- 
SM + Med, N=29 
SS + PT + CBT, N=25 
AS + CS, N=26 
OS (Arthroplasty), N=26 
60 
Self-reported 
success  
(Patient satisfaction). 
- 
SM: 72% 
Reh: 81% 
AS: 76.2% 
OS: 83.3% 
(ITT) 
II-1 
Turley (1993) 
(237) 
CR 1 
DDwoR 
(CL) 
- 1 - 23 5 - 
Arthroplasty (discectomy 
with sialistic implant 
replacement) 
72 
MMO≥40mm, 
improved function, & 
stable occlusion 
- - IV 
Widmark et 
al. (1997) 
(238) 
RCS 
20 
(4) 
DDwoR 1 15 21-71 37 18-150 48 Discectomy 6-42 
Improvement in: VAS 
Pain & jaw function 
(CMI) 
- 
88% 
(no ITT) 
IV 
Zhang et al. 
(2010) (239) 
PNCoSt 81 
W: III-IV  
69
 c
 
23 58 23-74 38.5 0.5-60 12.06 
Disc repositioning by bone 
anchores 
0.25 DR on MRI - 96.3% III-3 
TOTAL 8studies - DDwoR - - - - 0.5-150 21.86 OS - - - 86.3% - 
Study Design abbreviations: RCT: randomised controlled trial, Q-RCT: quasi-randomised controlled trial, PCoSt: prospective comparative study, RCoSt: retrospective comparative study, PCCSt: prospective case-control study, PNCoSt: 
prospective non-comparative study, RNCoSt: retrospective non-comparative study, FSt: follow-up study, PCS: prospective case series, RCS: retrospective case series, BACS: before-after case series, BACR: before-after case report, CR: 
case report. 
Abbreviations: AC: arthrocentesis, ACL: acute closed lock, ARS: anterior repositioning splint, AS: arthroscopy, CBT: cognitive behavioural therapy, CCL: chronic closed lock, Ch: chronic, CMI: craniomandibular index, cMMO: comfortable 
‘painless’ maximum mouth opening, CS: corticosteroids, Ctrl: control, DAL: daily activity limitation, DDwoR: disc displacement without reduction, DR: disc recapturing, drop: drop-outs, dy: day, exc: excluded, Exr: exercises, F: female, GA: 
general anaesthesia, ID: internal derangement, IL: intermittent locking, ITT: intention-to-treat analysis, IV: intra-venous, j: joint, LA: local anaesthesia, LDF: limitation in daily function, LM: lateral movement, M: male, Med: medication, 
MFIQ: mandibular function impairment questionnaire, mm: millimetres, MMO: maximum mouth opening, mo: month, MR: muscle relaxant, MRI: magnetic resonance imaging, N: number of patients, NR: not reported, NS: non-surgical, 
NSAIDs: non-steroidal anti-inflammatory drugs, OS: open surgery, PM: protrusive movement, PM: pumping manipulation, PS: pivot splint, PT: physiotherapy, Reh: rehabilitation, S&S: signs and symptoms, SD: standard deviation, SG: 
successful group, SH: sodium hyaluronate, SM: self-management, SS: stabilization splint, Sub-ac: sub-acute, UG: unsuccessful group, VAS: visual analogue scale, W: Wilkes staging of internal derangement, wk: week, yr: year. 
a
 Separate data provided are for CL patients only. 
b
 Study data are also provided in other tables according to main treatment modality assessed. 
c
 DDwoR patients in study sample ≥ 80%. 
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Title: Timing interventions in relation to temporomandibular joint closed lock duration: a 
systematic review of ‘locking duration’ 
Appendixes: 
Appendix 1: Medline search strategy  
Ovid MEDLINE(R) <1946 to August Week 1 2013> 
 
1. exp Temporomandibular Joint disorders/   
2. exp Temporomandibular Joint/ 
3. 1 or 2 
4. (lock$ adj2 (closed or jaw)).tw. 
5. ((displace$ without or dislocat$ without or unreduc$ or nonreduc$ or un-reduc$ or non-reduc$ 
or derange$ without) adj6 (disc or disk or meniscus)).tw. 
6. 4 or 5 
7. 3 and 6 
8. limit 7 to (english language and humans)  
9. limit 8 to "review articles" 
10. 8 not 9 [RESULT = 426] 
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Appendix 2 (Table): A modified designation of levels of evidence (1).  
Level of evidence Study design 
I 
 
Evidence obtained from a systematic review of all relevant randomised controlled trials. 
II-1 
 
Evidence obtained from at least one properly-designed randomised controlled trial. 
II-2 
 
Evidence obtained from at least one poorly-designed randomised controlled trial. 
III-1 
Evidence obtained from well-designed pseudo-randomised controlled trials (alternate 
allocation or some other method of quasi-randomisation). 
III-2 
Evidence obtained from comparative studies (including systematic reviews of such 
studies) with concurrent controls and allocation not randomised, cohort studies, case-
control studies, or interrupted time series with a control group. 
III-3 
Evidence obtained from comparative studies with historical control, two or more single 
arm studies, or interrupted time series without a parallel control group. 
IV Evidence obtained from case series, either post-test or pre-test/post-test. 
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Figure legend:  
Appendix 3 (Figure): Study flow diagram. 
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Appendix 4 (Table): Diagnostic criteria for DDwoR (2). 
DC/TMD for DDwoR 
DDwoR with limited mouth opening: 
- The history of both of the following must be present: 
1. Jaw lock or catch so that the mouth will not open all the way. 
2. Limitation in jaw opening severe enough to interfere with the ability to eat. 
- The clinical examination should confirm that the maximum assisted opening (passive stretch) is 
less than 40mm, including the vertical incisal overlap. 
In addition, although not required, any of the following may help to corroborate the diagnosis: 
 Deflection during mouth opening to the affected side. 
 Limited lateral movements especially toward the contralateral side. 
- If the clinical diagnosis needs to be confirmed, the radiographic examination by MRI should reveal 
both of the following: 
1. In the closed-mouth position (the maximal intercuspal position), the posterior band of the disc is 
located anterior to 11:30 clock position and the intermediate zone of the disc is located anterior 
to the condylar head. 
2. In full mouth-opening position, the intermediate zone of the disc is located anterior to the 
condylar head. 
 
DDwoR without limited mouth opening: 
- The history of both of the following must be present: 
1. Jaw lock or catch so that the mouth will not open all the way. 
2. Limitation in jaw opening severe enough to interfere with the ability to eat. 
- In addition, the clinical examination should confirm that the maximum assisted opening (passive 
stretch) is at least 40mm, including the vertical incisal overlap. 
- If the clinical diagnosis needs to be confirmed, the radiographic examination by MRI should reveal 
both of the following: 
1. In the closed-mouth position (the maximal intercuspal position), the posterior band of the disc is 
located anterior to 11:30 clock position and the intermediate zone of the disc is located anterior 
to the condylar head. 
2. In full mouth-opening position, the intermediate zone of the disc is located anterior to the 
condylar head. 
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Appendix 5 (Table): Summary of studies’ definition of acute/chronic closed lock stages according to 
locking duration. 
Locking 
duration 
Acute/Chronic CL 
stages’ definition 
Study (year) 
1 month 
ACL<1month or  
CCL>1 month 
Yuasa and Kurita, 2001(3); Sembronio et al., 2008(4); 
Saitoa et al., 2010(5); Ghanem, 2011(6) 
1.5 - 2 
months 
ACL<1.5-2 months or 
CCL>1.5 months 
Van Dyke and Goldman, 1990(7); Dimitroulis, 2002(8) 
2 months 
ACL<2 months or  
CCL>2 months 
Nadler, 1988(9); Ozawa et al., 1996(10); Holmlund et 
al., 2001(11); Hamada et al., 2005(12) 
3 months CCL>3 months Kumagai et al., 2010(13) 
3 – >6 
months 
ACL<3 months,  
Sub-ACL=3–6 months, & 
CCL>6 months 
Stiesch-Scholz et al., 2002(14) 
3 – >9 
months 
Sub-ACL=3–9 months &  
CCL>9 months 
Clark et al., 1991(15) 
4 months 
ACL<4 months or  
CCL>4 months 
Ness and Crawford 1996(16); Casares et al., 1999(17) 
6 months 
ACL<6 months or  
CCL>6 months 
Kuwahara et al. (1990); Murakami et al., 1995(18); 
Hosaka et al., 1996(19); Emshoff and Rudisch, 
2004(20); Emshoff, 2005(21); Politi et al., 2007(22); 
Schiffman et al., 2007(23) 
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Appendix 6 (Table): Description of reviewed interventions 
Intervention  Description  
Mandibular 
manipulation (MM) 
 Unlock manipulation (UM): any manual manipulation technique used to 
restore the displaced disc into its normal anatomical position. 
 Pumping manipulation (PM): any adjunctive technique used to inflate the 
joint space by joint space pumping and hydraulic pressure to assist the 
manipulation in recapturing the displaced disc. 
Self-management 
(SM) 
Any self-management programmes involving self-care instructions + 
medications (over-the-counter analgesics, muscle relaxants, NSAIDs) ± self-
exercises. 
Physiotherapy (PT)  Any active or passive jaw stretching ‘repeated’ exercises. 
 Any electro-physiotherapy such as: ultrasound therapy, short wave 
diathermy, iontophoresis, transcutaneous electric nerve stimulation (TENS), 
pulsed electromagnetic fields (PEMF), or low level laser therapy (LLT). 
Splint therapy Any type of splint such as: stabilization splint (SS), anterior repositioning splint 
(ARS), pivot splint (PS), soft splint…etc. 
Combination therapy Any splint + PT ± SM 
Arthrocentesis (AC) Any technique using needles and injections for joint washing and lavage 
inside the superior joint space. 
Arthroscopy (AS) Any technique using an arthroscope for joint hydraulic pumping and lavage 
and/or any other operative arthroscopic operations inside the superior joint 
space. 
Open surgery (OS) Any procedure using a skin incision to approach the temporomandibular joint 
such as discoplasty, discectomy, eminectomy, or condylectomy. 
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Figure legend:  
Appendix 7 (Figure). Farrar’s manipulation technique to ‘unlock’ the jaw.  
The method involves: Instructing the patient to move the jaw as far as possible toward the opposite 
‘unaffected’ side; grasping the mandible firmly with the clinician’s thumb placed intra-orally over the 
occlusal surfaces of the mandibular molar teeth at the affected side and the fingers grasp the inferior 
border of the mandible extra-orally; stabilizing the cranium with the other hand; and applying gentle 
but firm force downward on the molar teeth at the affected side by the thumb and upward on the chin 
with the fingers; and then pulling the mandible downward and forward and to the opposite ‘unaffected‘ 
side, to enable the condyle to move under the ‘thick’ posterior band of the displaced disc, and the disc 
returns back to its normal position above the condyle. [Reprinted from Farrar (24), copyright (1978), 
with permission from Elsevier]. 
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